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Hypercholesterolemia is a significant risk factor in the development of 
cardiovascular disease and is associated with chronic leukocyte adhesion in the 
microvasculature. While the underlying mechanisms behind this have yet to be determined, 
it may be possible that hypercholesterolemia impairs the fluid shear stress (FSS) 
inactivation of neutrophils through the rigidifying effect of cholesterol on membrane 
fluidity. FSS restricts surface expression of CD18 integrins through cathepsin B (ctsB) 
proteolysis, which minimizes neutrophil adhesivity. If hypercholesterolemia blocks FSS 
mechanotransduction, then the inhibition of CD18 cleavage may link pathologic blood 
cholesterol elevations with dysregulated neutrophil adhesion. We hypothesized that 
elevated cholesterol contributes to dysregulated neutrophil adhesion by impairing ctsB 
FSS-induced CD18 cleavage through membrane fluidity changes. 
In the first part of this study, we demonstrated that FSS-induced CD18 cleavage is 
a robust response of neutrophils and involves selective cleavage of macrophage 1-antigen 
(Mac1) through ctsB proteolysis. The second part of this study confirmed that ctsB 
regulates neutrophil adhesion through its proteolytic actions on Mac1, an important 
integrin involved in adhesion and chemotaxis. Specifically, ctsB accelerated neutrophil 
motility through an effect on Mac1 integrins during pseudopod retraction. Furthermore, by 
using a flow-based assay to quantify the mechanoregulation of neutrophil adhesivity, we 
demonstrated that FSS-induced ctsB release promoted neutrophil detachment from 
platelet-coated substrates and unstimulated endothelium. For the third part of this study, 
we linked cholesterol-related membrane fluidity changes with the ability of FSS to restrict 
neutrophil adhesion through Mac1. We also determined that pathologic cholesterol 
elevations associated with hypercholesterolemia could block FSS-induced Mac1 cleavage 
and were linked to disrupted tissue blood flow. This was accomplished using low-density 
lipoprotein receptor deficient (LDLR-/-) mice fed a high-fat diet. 
Ultimately, the results provided in the present study confirmed that cholesterol-
related changes in membrane fluidity blocked the ability of ctsB to regulate neutrophil 
adhesion through FSS-induced Mac1 cleavage. This implicates an impaired neutrophil FSS 
mechanotransduction response in the dysregulation of neutrophil adhesion associated with 
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hypercholesterolemia. Since dysregulated adhesion may be one of the earliest upstream 
features of cardiovascular disease associated with hypercholesterolemia, the present study 
provides a foundation for identifying a new mechanobiological factor in the pathobiology 
of microcirculatory dysfunction. 
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CHAPTER 1: INTRODUCTION 
  Cardiovascular disease is one of the leading causes of death for adults, with over 
1.5 million cases each year in the United States [1]. By studying the upstream risk factors, 
it may be possible to reduce the lethality of cardiovascular disease and prevent death. 
Hypertension and hypercholesterolemia represent two diseases associated with 
cardiovascular disease [2,3]. Patients with these conditions are likely to exhibit chronic 
inflammation in the blood and microvascular dysfunction, two risk factors linked to the 
development of lethal cardiovascular disease [4-6]. Historically, increased numbers of 
activated leukocytes in the blood and microcirculation are associated with cardiovascular 
disease [7-10], suggesting that dysregulated leukocyte activity may contribute toward 
cardiovascular pathogenesis. 
  Neutrophils, the most numerous leukocyte subtype in the blood under physiological 
conditions, are among the first responders of the acute inflammatory response [11]. These 
cells are highly sensitive to stimuli, and can rapidly activate in the presence of as little as 
10 – 100 bacterial peptides [12]. Due to this high sensitivity and their vast destructive 
potential, it is possible that the neutrophils are highly susceptible to pathogenic factors and, 
thus, serve as one of the earliest contributors to the onset of chronic inflammation. This 
possibility is conceivable since tight regulation of neutrophil activity is essential to 
maintain the body in a non-inflamed state. Failure to do so may result in sustained 
neutrophil activation which contributes to lethal tissue injury [13] via an autodigestive 
process, where dysregulated release of cytokines (which activate more inflammatory cells) 
and biodegradative agents (e.g., reactive oxygen species, proteases, etc.) cause damage to 
healthy vasculature [14]. Alternatively, sustained neutrophil activation in the blood may 
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damage tissues indirectly by impacting blood rheology and impairing tissue perfusion [15]. 
Finally, progression of a chronic inflammatory state in the circulation could initiate from a 
combination of both processes [16]. 
  Although neutrophil inactivity is predicated on the absence of inflammatory 
stimuli, several cellular and molecular mechanisms are in place to ensure that these cells 
remain inactivated under physiologic conditions [17,18]. Recent evidence established fluid 
shear stress (FSS) mechanotransduction as one potential regulatory mechanism [19]. 
Whether neutrophils are adherent or freely-floating, their activity is minimized by exposure 
to FSS typical of the physiologic bloodstream, ensuring their circulation as rounded, 
inactivated cells [20-22]. FSS inactivates neutrophils by minimizing pseudopod activity 
and restricting their surface expression levels of CD18 integrins via a cleavage process 
involving the release of lysosomal cysteine protease, cathepsin B (ctsB) [23]. These FSS 
responses are thought to be important aspects of neutrophil regulation since their 
impairment has been implicated as a potential contributor to pathological elevations in 
peripheral vascular resistance [24,25]. 
  To determine how neutrophil FSS mechanotransduction may become impaired and 
contribute to microvascular pathogenesis, recent studies from our lab focused on the 
cholesterol-related membrane fluidity of the cells [26,27]. This focus on cell membrane 
fluidity was predicated on the principle that changing cell membrane mechanical properties 
may alter the ability of FSSes to induce conformational (i.e., structural) activity in putative 
mechanosensors on the neutrophil surface.  Considering that cholesterol is an important 
lipid regulator of the membrane fluidity of mammalian cells [28], changes in membrane 
cholesterol content may conceivably alter cell sensitivity to physical stimuli. 
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  One scenario for which the cholesterol-related membrane properties may change 
and lead to dysregulation of the neutrophils is hypercholesterolemia. Pathological blood 
cholesterol elevations that occur during hypercholesterolemia are associated with chronic 
leukocyte activation in the blood and microcirculation as well as microvascular dysfunction 
[29]. By using pseudopod retraction to estimate FSS mechanosensitivity, cholesterol-
related changes in membrane fluidity were demonstrated to impair neutrophil 
mechanotransduction and to be linked with the onset of microvascular dysfunction due to 
hypercholesterolemia [26,27]. However, it remained to be determined how the impaired 
neutrophil responsiveness to FSS, which was quantified by using pseudopod retraction as 
a surrogate marker, manifested into microvascular dysfunction. The present study focused 
on the possibility that an impaired ability of FSS to limit neutrophil CD18 surface 
expression may explain the connection between hypercholesterolemia, dysregulated 
neutrophil adhesion, and dysregulated microvascular function. For these purposes, the 
present study tested the hypothesis that pathological blood cholesterol elevations 
dysregulate neutrophil adhesion by reducing membrane fluidity and impairing FSS-
induced ctsB release which blocks CD18 cleavage. 
  To address this hypothesis, the following specific aims were carried out: 
1) Link ctsB release with reduced expression of neutrophil adhesion molecules. 
2) Show that ctsB activity minimizes neutrophil adhesion under shear exposure. 
3) Verify that neutrophil adhesion and detachment under flow is affected by 
cholesterol-related changes in membrane fluidity. 
4) Demonstrate that extracellular cholesterol elevations, similar to that of 
hypercholesterolemia in vivo, block FSS regulation of neutrophil adhesion. 
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CHAPTER 2: BACKGROUND 
2.1 The Potential Impact of Neutrophil Activation on Blood Flow 
 As the most numerous leukocytes in the body, the neutrophils are second only to 
the red blood cells (RBCs) in their impact on microvascular flow. Under physiologic 
conditions, inactivated neutrophils patrol the circulation as spherical, non-adhesive cells. 
This state enables their passive deformation through the microcirculation, ensuring that 
they have a minimal impact on blood flow while inactivated [30]. Once activated, however, 
neutrophils are capable of influencing blood rheology through changes to their cellular 
geometry and adhesivity (Fig. 2.1). 
 
 
 
  
Figure 2.1. The effects of neutrophil activation on microvascular blood flow. 
Blood flow through non-capillary vessels can be impaired by neutrophil activation. Activated 
neutrophils may project pseudopods which elevate the viscosity of blood. Alternatively, 
activated neutrophils may adhere to the endothelium and reduce the apparent diameter of the 
vessel. In both cases, resistance to flow is elevated due to the changes in viscosity or diameter. 
In the case of the capillaries, activated neutrophils have been demonstrated to plug capillaries. 
This restricts blood flow and elevates the resistance to flow. 
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Neutrophils activate in response to stimulation with inflammatory agonists, such as 
formyl-methionyl-leucyl-phenylalanine (fMLP) or platelet-activating factor (PAF) [15]. 
The most visible change that accompanies neutrophil activation is the extension of 
pseudopods, causing the cell to adopt an irregular geometry [13]. In addition to projecting 
pseudopods, neutrophils also upregulate their expression of CD18 cell-cell adhesion 
molecules when stimulated with inflammatory agonists [31]. In these ways, neutrophil 
activation may potentially impact blood rheology and flow within the microcirculation as 
described in the following sections. 
 
2.1.1 The rheological effects of activated neutrophils on microvascular flow 
Activated neutrophils in the blood are capable of physically influencing 
microvascular flow and thus affecting peripheral resistance. This influence may be roughly 
inferred from the Hagen-Poiseuille approximation in the following forms: 
Ω ∝ µ/Ac (microvessel network) 
or 
 Ω ∝ µ/D4 (single vessels) 
where Ω is microvessel resistance, µ is cell suspension viscosity, Ac is total cross-sectional 
area to flow, and D is vessel diameter. This relationship exemplifies how changes in either 
the blood apparent viscosity or the microvasculature geometry may affect flow resistance. 
In microvascular networks, inactivated neutrophils with diameters of 12–15 μm are 
capable of deforming and squeezing through capillaries with diameters of 5–10 μm [32,33]. 
However, activated neutrophils express F-actin enriched pseudopods and are far less 
deformable, which may lead to capillary plugging (Fig. 2.1, Plugging Effect) [34]. A 
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significant degree of capillary plugging in microvascular networks, which would manifest 
as a reduction in the total cross-sectional area to flow of capillary beds, would lead to 
increased peripheral resistance. Because the capillaries make up the greatest total cross 
sectional area in the body [35], a significant degree of capillary plugging can have a great 
effect on flow resistance. 
Activated neutrophils may also have an effect on microvascular flow within the 
non-capillary microcirculation. Presumably, the presence of pseudopod projections on 
neutrophils causes them to adopt irregular, non-spherical shapes that increase their 
tumbling behavior in the linear velocity gradient of the blood flow field within vessels. 
This enhanced tumbling may increase the number of collisions they experience with other 
cell types, including the numerous RBCs in the surrounding environment [36,37].  As 
RBCs are displaced laterally toward the low viscosity cell-free plasma layer located near 
the vessel wall [38], the apparent viscosity of the blood is elevated (Fig. 2.1, Viscous 
Effect). According to the Hagen-Poiseuille approximation, this means flow resistance is 
increased in response to activated neutrophils, due to pseudopod-induced elevations in the 
apparent viscosity of blood in the non-capillary microvasculature (10 – 300 μm in diameter 
[39]) which make up a large percentage of microvessels in the microcirculation. This 
potential influence of cell activation and viscosity on flow resistance was supported by in 
vivo evidence, where interactions between activated leukocytes and RBCs in blood-like 
cell suspensions elevated both apparent viscosity and flow resistance [40]. 
It may also be possible for activated neutrophils to alter microvascular resistance 
by adhering to the non-capillary microvasculature, particularly the venules. Upregulation 
of CD18 integrins on activated neutrophils causes these cells to become much more 
7 
adhesive than their inactivated counterparts. Consequently, the apparent diameter of a 
microvessel may decrease if significant numbers of rolling and migrating neutrophils are 
present on the microvascular walls (Fig. 2.1, Geometric Effect). According to the Hagen-
Poiseuille approximation, it may be possible that a reduction in apparent diameter would 
elevate microvascular resistance, due to the inverse 4th power relationship between 
resistance and diameter. In support of this, studies have shown that inflammatory 
stimulation can promote leukocyte adhesion and migration in the capillaries and non-
capillary microvessels, with an enhancing effect on microvascular resistance [41].  
 
2.1.2 The effects of activated neutrophils on endothelial cell functions 
It is important to note that the previously described mechanisms have focused on 
the rheological effects of neutrophil activation alone. However, neutrophils may also affect 
microvascular flow by biologically modifying the activity of other cells. For example, their 
binding may influence the activity of endothelial cells responsible for regulating blood flow 
through the release of signaling molecules (i.e., nitric oxide, prostacyclin, thromboxane, 
endothelin) [42]. Endothelial signaling in response to changes in the intravascular 
environment can lead to the dilation or constriction of vascular smooth muscle, altering the 
microvascular resistance to blood flow [42,43]. Alternatively, signaling molecules can 
change the permeability of the endothelium, leading to a net transfer in fluid from the 
venules to the interstitial tissues which may alter interstitial pressures and physically 
interfere with the function of neighboring arterioles [44,45].  
It is difficult for circulating neutrophils to affect endothelial cell activity, due to the 
extracellular fluid containing antioxidants and protease inhibitors which limit leukocyte 
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cytotoxicity under physiologic conditions [46]. However, the recruitment/adhesion of 
neutrophils to endothelial cells creates a sequestered “microenvironment” which enables 
neutrophil oxidants and proteases to overwhelm these restrictive factors [47,48]. This 
enables adhesive neutrophils to exert their full cytotoxic effects, which are capable of 
altering the activity of endothelial cells [14,49]. Importantly, the secretion of endothelial 
products and the permeability of endothelial cells may be altered by adhesive neutrophils 
[50,51]. This suggests that sustained neutrophil adhesion to the microvascular wall may 
lead to dysregulated endothelial cell activity in the microvasculature (Fig. 2.2). The 
impaired secretion of endothelial productions responsible for vasomotor control, for 
example, would affect microvascular flow resistance [52], leading to disrupted tissue blood 
flow and microvascular dysfunction. Additionally, increased endothelial permeability may 
have paracrine or systemic effects, where the surrounding cells are affected by cytokine 
release [53,54]. These surrounding cells would then activate and secrete more cytokines, 
promoting a chronic inflammatory state that sustains dysregulated neutrophil and 
endothelial cell activity. 
In summary, dysregulated neutrophil activity may disrupt tissue blood flow either 
directly through a physical effect or indirectly through actions on endothelial cells of the 
microvasculature. This possibility implicates the neutrophils as a critical feature of 
microvascular blood flow rheology. It also suggests that dysregulation of the neutrophils 
may contribute to microvascular dysfunction and downstream lethal pathologies due to 
factors that affect their responsiveness to FSS (e.g., hypercholesterolemia). 
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2.2 Control of Neutrophil Activity by Fluid Shear Stress Mechanotransduction 
2.2.1 Fluid shear stress induces retraction of neutrophil pseudopod projections 
 A growing body of evidence points to the mechanotransduction of hemodynamic 
FSS (i.e., 1 – 10 dyn/cm2) [41] as a potential control mechanism in the blood for the purpose 
of restricting leukocyte activity under physiological conditions, when their recruitment is 
not needed [19,21,23]. FSS-induced pseudopod retraction represents one of the most overt 
evidence in support of the ability of fluid flow mechanotransduction to promote neutrophil 
deactivation. Within 1 – 2 minutes of being exposed to FSS (1 – 2 dyn/cm2) using a 
Figure 2.2. The proposed impact of neutrophil activation on hemodynamic resistance 
and blood flow regulation in microvessels. 
Flow resistance may be altered by the effects of activated neutrophils on endothelial cells. 
This may manifest as either dysregulated cytokine release or increased tissue permeability, 
both of which contribute to microvascular dysfunction. Ultimately, sustained neutrophil and 
endothelial cell activation promote a chronic inflammatory state that can lead to lethal 
cardiovascular disease. The impact of the neutrophils here is focused on blood flow in the 
non-capillary vessels. 
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micropipette, neutrophils migrating on glass substrates retract F-actin enriched pseudopods 
and adopt a rounded morphology [21]. It appears as though FSS exposure interferes with 
the ability of neutrophils to project pseudopods, since the F-actin content of neutrophils 
will rapidly decrease in parallel with their pseudopod retraction response [55]. FSS has 
also been demonstrated to reduce the phagocytic behavior of neutrophils, which relies on 
the formation of pseudopods [56]. These observations support the ability of shear to 
mechanobiologically restrict or limit pseudopod activity. 
 
2.2.2 Fluid shear stress induces cleavage of CD18 by cathepsin B release 
FSS downregulates the expression of intact CD18 adhesion molecules that mediate 
firm adhesive interactions with substrates [23]. CD18 is the common β2 polypeptide 
subunit for a family of heterodimeric integrins [57]. Of the four CD18 subtypes, the two 
most numerous on the neutrophil surface are lymphocyte function-associated antigen 1 
(LFA1; CD11a/CD18) and macrophage-1 antigen (Mac1; CD11b/CD18). LFA1 is 
typically associated with loose capture interactions which promote neutrophil arrest during 
inflammatory recruitment, and Mac1 supports the firm adherence of neutrophils to venular 
walls, either directly on endothelium or via platelet bridges [58]. 
Reportedly, FSS-induced downregulation of CD18 expression involves proteolytic 
cleavage of excess amounts of these integrins off the neutrophil surface. During in vitro 
studies after harvest from fresh blood, reintroducing neutrophils to venular-level shear 
stress (1.5 – 5 dyn/cm2) for as short as 5 minutes cleaves approximately 20 – 30% of cell 
surface-associated CD18 integrins. This shedding process involves the FSS-induced 
release of lysosomal cysteine protease ctsB at the cell surface [23]. Previous studies 
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identified the role of ctsB through the use of broad-spectrum protease inhibitors. Blocking 
the activity of several different protease families, such as serine or aspartyl proteases, did 
not prevent the FSS-induced cleavage of CD18 integrins. However, blocking the activity 
of cysteine proteases inhibited FSS-induced CD18 cleavage [23]. This inhibition was also 
observed when ctsB activity was selectively blocked; however, selectively blocking other 
cysteine proteases had no effect on FSS-induced CD18 cleavage. 
Recently, our lab demonstrated that CD18 cleavage by neutrophils exposed to FSS 
is specific for Mac1 and occurs in parallel with their reduced binding to platelets and 
fibrinogen [59]. This suggested that Mac1 cleavage serves to reduce or prevent neutrophil 
adhesion under flow. However, the underlying mechanism, including the protease 
responsible for cleaving the CD11b subunits of Mac1, remained to be elucidated. 
Furthermore, because Mac1 plays a role in firm adhesion, it remained to be demonstrated 
whether ctsB-induced Mac1 cleavage restricted neutrophil binding to unstimulated 
endothelium under flow. 
 
2.2.3 Agonist stimulation overrides fluid shear stress mechanotransduction 
Inactivation of neutrophils by FSS mechanotransduction occurs even in the 
presence of low amounts of inflammatory agonists. Mild stimulation of neutrophils with < 
1 µM fMLP or < 10 µM PAF does not compromise their ability to retract pseudopods when 
exposed to FSS [19-21,27,60]. In contrast, stimulation of neutrophils with these same 
agonists above their critical thresholds abolishes FSS-induced pseudopod retraction [20]. 
Intuitively, this dose-dependent relationship between agonist stimulation and impairment 
of neutrophil deactivation under FSS makes sense. It is consistent with the likelihood that 
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inflammatory agonists are capable of overriding the FSS-induced deactivation of 
neutrophils, such as during acute inflammation when they are needed to respond to 
infection or tissue injury. 
Interestingly, deactivation of neutrophils under FSS exposure is linked with their 
surface expression of G protein-coupled receptors (GPCRs) such as the formyl peptide 
receptor (i.e., fMLP receptor) [61]. The desensitization of FPR by fMLP ligand binding is 
typically associated with receptor internalization [62]. However FPR is reportedly 
internalized into perinuclear compartments under shear exposure [63]. It has been 
demonstrated that the shear-induced internalization of FPR causes neutrophils to resist 
activation in response to low concentrations of fMLP [64]. This is in line with the 
inactivation of neutrophils by FSS exposure in the presence of low quantities of 
inflammatory agonists. Furthermore, it is possible that stimulation with agonists, such as 
fMLP, above a threshold level, prevents FSS-induced GPCR internalization, and thus, the 
neutrophils activate in spite of the local flow environment. 
Overall, FSS mechanotransduction serves to maintain neutrophils in an inactivated 
state. However, under some circumstances it is possible for neutrophils to become 
unresponsive to FSS exposure. In the event that the FSS mechanotransduction response 
becomes impaired, the dysregulation of neutrophil activity may have detrimental effects 
on microvascular physiology. 
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2.3 Consequences of Impaired Neutrophil Fluid Shear Stress Mechanotransduction 
To date, there is an accumulation of evidence suggesting that, under physiologic 
conditions, FSS serves to minimize the activity of neutrophils in the bloodstream unless 
there is sufficient agonist stimulation to override this control mechanism. However, it is 
also possible that FSS mechanotransduction becomes compromised due to the onset of 
pathological conditions. Presumably, this impairment in the FSS mechanotransduction 
response results in dysregulated neutrophil activation that eventually drives a chronic 
inflammatory phenotype in the body. 
Neutrophils promote an inflammatory phenotype by releasing cytokines and cell 
agonists that not only promote tissue injury, but also recruit other leukocytes [65,66]. As a 
result, the dysregulated activity (i.e., sustained activation) of neutrophils and other 
leukocytes can damage host tissue and promote the development of chronic inflammation, 
a common denominator for a wide variety of lethal pathologies (e.g., microvascular 
dysfunction, cardiovascular disease, diabetes, cancer, etc.) [67,68]. Since neutrophils are 
among the first leukocytes recruited during inflammation, their sustained activity due to 
impairment of regulatory mechanisms may be one of the earliest upstream factors driving 
the dysregulation of microvascular flow associated with chronic inflammation (Fig. 2.3). 
In line with this, past studies have linked an impaired FSS mechanotransduction response 
with dysregulated neutrophil activity and microvascular dysfunction. 
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Evidence that impaired neutrophil mechanosensitivity contributes to microvascular 
dysfunction has been reported for rats exhibiting a chronically inflamed phenotype as a 
result of spontaneous hypertension [24,25,69]. Spontaneously hypertensive rats (SHRs) 
were found to have significantly elevated hemodynamic resistance due to the sustained 
Figure 2.3. The potential impact of impaired neutrophil fluid shear stress 
mechanotransduction on microvascular rheology. 
The regulation of neutrophil activity under physiologic conditions, represented by the blue 
arrows, ensures neutrophils remain quiescent under non-inflamed conditions. This is 
accomplished, in part, due to the inactivation of neutrophils by FSS mechanotransduction. 
Exposure to pro-inflammatory stimuli temporarily overrides the FSS mechanotransduction 
response and activates neutrophils, leading to inflammation. When inflammation is resolved 
and agonist levels subside, neutrophils become responsive to FSS mechanotransduction once 
more and are inactivated. Impairment of FSS mechanotransduction by pathologic conditions, 
represented by the red arrows, can lead to sustained neutrophil activation in the blood. This, 
combined with the elevated expression of pro-inflammatory cytokines, promotes a chronic 
inflammatory state. The accumulation of activated neutrophils during chronic inflammation is 
thought to contribute to microvascular dysfunction. 
15 
levels of chronically activated neutrophils [25]. The neutrophils from SHRs were found to 
be unresponsive to FSS exposure. Unlike wild type (WT) neutrophils which retracted 
pseudopods in the presence of shear, SHR neutrophils lacked a functioning pseudopod 
retraction response. The persistent presence of pseudopods on SHR neutrophils in the 
bloodstream were reported to contribute to the elevations in microvascular resistance 
associated with hypertension [70,71].  
It should be noted that spherical leukocytes in the blood might increase apparent 
viscosity and elevate microvascular flow resistance due to their interactions with RBCs in 
the flow field [37,72]. This connection may be explained by the presence of pseudopod 
projections on neutrophils, which enhance their tumbling and exacerbate their impact on 
surrounding RBC motion, ultimately elevating both apparent viscosity and microvascular 
resistance to a higher degree than if cellular projections were not present. Recently, we 
reported that mixed suspensions of activated leukocytes and hematocrit elevate the flow 
resistance of non-capillary microvascular mimics to a greater degree than similar 
suspensions with inactivated leukocytes alone (Fig. A.1 and Fig. A.2, Appendix A) [73]. 
However, although pseudopod extensions had a significant effect on microvascular flow 
resistance in vitro, the magnitude of these flow resistance elevations may not be 
biologically relevant to induce pathology in vivo. 
Further evidence regarding impaired neutrophil mechanosensitivity and its putative 
involvement in microcirculatory pathogenesis came from previous studies from our lab 
using a hypercholesterolemia murine model. Hypercholesterolemia induces a chronic 
inflammatory phenotype within the microcirculation, which drives downstream 
microvascular dysfunction. When neutrophils were taken from the hypercholesterolemic 
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mice and exposed to shear, these cells were found to have impaired FSS 
mechanosensitivity; specifically, they were deficient in their pseudopod retraction response 
to shear exposure [27]. Furthermore, this impaired FSS pseudopod retraction response was 
correlated with disrupted tissue blood flow autoregulation (i.e., microvascular dysfunction) 
[26], implicating a link between dysregulated neutrophil activity and microvascular 
dysfunction. Combined, these observations suggested that the pathologic cholesterol 
elevations associated with hypercholesterolemia played a role in the impairment of 
neutrophil FSS mechanosensitivity. 
 
2.4 Hypercholesterolemia-Associated Dysregulation of Neutrophil Adhesion 
2.4.1 Dysregulated neutrophil adhesion is a key feature of hypercholesterolemia 
Hypercholesterolemia is associated with chronically inflamed blood typified by 
elevations in the number of activated neutrophils in the microcirculation [74]. One of the 
first features to manifest during hypercholesterolemia appears to be sustained neutrophil 
adhesion in the blood and microcirculation. The formation of leukocyte-platelet 
aggregates, for example, is reportedly enhanced in hypercholesterolemic mice [75]. 
Additionally, neutrophils also exhibit increased adhesivity to endothelium in 
hypercholesterolemic rabbits [76]. This enhanced adhesion may be due to the increased 
Mac1 expression reported for neutrophils subjected to a hypercholesterolemic environment 
[77]. Sustained neutrophil adhesion, in turn, may drive endothelial cell dysfunction [74,78], 
leading to tissue blood flow dysregulation and microvascular dysfunction. 
Many factors potentially contribute to the reported dysregulation in neutrophil 
adhesion during hypercholesterolemia. For example, superoxide production by neutrophils 
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positively correlates with plasma cholesterol levels [79]. The enhanced production of 
superoxide, in turn, reduces the bioavailability of nitric oxide (NO), a mediator of 
neutrophil adhesion [80]. Notably, impaired NO production by endothelial cells supports 
dysregulated neutrophil adhesion [81]. This means a combination of enhanced superoxide 
production and reduced NO availability may promote dysregulated neutrophil adhesion 
and sustain the chronic inflammatory phenotype observed during hypercholesterolemia. 
Interestingly, reduced NO levels in the blood have been linked to an impaired neutrophil 
FSS response [20], suggesting that neutrophil activity may become dysregulated. However, 
NO production may also be limited independently of neutrophils due to endothelial cell 
dysfunction [82], which further promotes adhesion and a chronic inflammatory phenotype. 
 
2.4.2 Dysregulated neutrophils impair the post-occlusive reactive hyperemia response in 
hypercholesterolemic mice 
Once adhered, neutrophils may contribute to microvascular dysfunction by 
dysregulating tissue blood flow. Conceivably, accumulation of chronically activated 
neutrophils dysregulates microvascular blood flow and disrupts vascular perfusion, leading 
to lethal tissue injury [83]. Research from our own lab involving neutrophil shear 
regulation during tissue blood flow autoregulation in response to post-occlusive reactive 
hyperemia (poRH) further supports this possibility [26]. 
The poRH response represents a transient overshoot in blood flow during recovery 
of microvascular tissues in response to a brief period of blood stasis, which elicits ischemia 
in downstream tissues [74,84]. PoRH is commonly used to assess the health state of 
microvascular function (e.g., tissue blood flow autoregulation). After the initiation of 
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reperfusion, the blood flow overshoot prior to its return to baseline is believed to occur due 
to initial vasodilation of blood vessels, enabling the rapid transport of blood to oxygen-
starved tissues [85]. Once blood flow has been restored and tissues are reoxygenated, 
vasoconstriction reduces flow back to pre-stasis levels.  While it is believed that endothelial 
cell functions (e.g., NO release) are involved in regulating blood flow during poRH [84], 
some studies suggest that factors outside the endothelial cells also play a role [86].  
Our prior research focused on the contributions of neutrophils to the impaired poRH 
response observed during hypercholesterolemia [26,27]. In particular, we found that an 
impaired poRH response was positively correlated with an impaired pseudopod retraction 
response to FSS (our surrogate index of shear sensitivity) and elevated cholesterol levels. 
As such, an impaired FSS response may represent one of the earliest contributing factors 
toward microvascular dysfunction associated with hypercholesterolemia by promoting 
tissue blood flow dysregulation. However, the mitigating event linking dysregulated 
neutrophil activity with hypercholesterolemia remained unclear. 
 One possible explanation for the impaired blood flow response to poRH observed 
for hypercholesterolemic mice may be related to dysregulated neutrophil adhesion [74-76]. 
Neutrophils in a hypercholesterolemic environment exhibit an upregulated expression of 
adhesion integrins [77]. This upregulated expression may be linked with an impaired FSS 
mechanotransduction response. Similarly to FSS-induced pseudopod retraction, FSS-
induced CD18 cleavage may also be impaired by pathological blood cholesterol elevations. 
This impairment may be the central link, which connects hypercholesterolemia, 
microvascular dysfunction, and dysregulated neutrophil adhesion. However, the 
mechanistic basis for this dysregulation remains to be demonstrated. 
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2.5 The Role of the Cell Membrane in Fluid Shear Stress Mechanosensitivity 
 Because blood borne cells, including the neutrophils, are likely to experience 
large fluctuations in shear stress levels as they circulate through the body [41,87], 
atypical shear distributions alone are more than likely not the cause of cellular 
dysfunction. Instead, it is conceivable that the mechanistic basis for the onset of 
dysregulated neutrophil activity due to hypercholesterolemia, or any pathological 
condition, arises from changes in the ability of neutrophils to sense and respond to the 
applied shear stresses (i.e., mechanosensitivity) in their local environment.  
The cell membrane, being positioned at the interface between the extracellular 
and intracellular milieu, is in a strategic position to regulate the mechanosensitivity of 
many different types of cells, including the neutrophils. In general, the cell membrane is 
the location for many different classes of membrane-spanning proteins, including various 
GPCRs, tyrosine kinase receptors, ion channels, and integrins [23,88-94]. Many of these 
proteins that have regions both inside and outside the cell have been proposed to serve as 
mechanosensors and/or mechanotransducers for a variety of cells, including endothelial 
cells, bone cells, and neutrophils [91,92,94]. 
 
2.5.1 Evidence of formyl peptide receptors as neutrophil mechanosensors 
 In the case of neutrophils, FPR has been implicated as a mechanosensor, which 
drives their downstream responses to shear (e.g., actin depolymerization, pseudopod 
retraction). Using HL60 derived neutrophilic cells, FPR was demonstrated as an important 
component of the FSS-induced pseudopod retraction response [92]. In fact, FPR expression 
alone appeared enough to confer the ability of HL60 cells to exhibit a pseudopod retraction 
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response to FSS. Specifically, while undifferentiated HL60 cells express low levels of FPR 
and lack the ability to form pseudopods, overexpressing FPR in HL60 cells imparted the 
ability to form pseudopods that retract under FSS exposure. Moreover, HL60 cells were 
prevented from retracting pseudopods by using siRNA to silence FPR expression [92]. 
While the exact involvement of FPR in mechanotransduction processes remains 
unknown, it appears as though FSS downregulates the surface expression of this receptor 
[63]. This downregulation does not involve the proteolytic activity of matrix 
metalloproteinases (MMPs) [64], which are capable of cleaving FPR [69]. Instead, it seems 
to involve FSS-induced internalization and relocalization of FPR from the surface to a 
perinuclear compartment, thereby reducing pseudopod activity [63]. It is interesting to 
note, however, that some FPRs must be present on the cell surface to regulate pseudopod 
activity, since proteolytic FPR cleavage impairs the FSS-induced retraction response in 
SHRs [69]. These findings further support the role of FPRs as neutrophil mechanosensors. 
 
2.5.2 Evidence of CD18 integrins as neutrophil mechanosensors 
In addition to FPR, the CD18 integrins expressed on neutrophils may also act as 
mechanosensors. When exposed to FSS, CD18 integrins undergo conformational shifts in 
their extracellular domains [93]. Reportedly, this structural activity is proposed to facilitate 
ctsB access to cleavage domains on the CD18 integrins (Fig. 2.4). Simultaneously, it may 
promote outside-in signaling capable of altering neutrophil activity. There is substantial 
literature evidence suggesting that CD18 integrins influence cell functions via inside-out 
as well as outside-in signaling [95,96]. There is also evidence that CD18 integrins play a 
role in FSS-induced mechanosignaling. For example, neutrophils adhered to substrates 
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through CD18 [97] have a functional pseudopod retraction response to FSS. Neutrophils 
adherent via β1 integrins do not. This suggests that integrin specificity plays a role in FSS 
mechanotransduction responses, further implicating CD18 as a potential mechanosensor.  
The reported FSS-induced conformational shifts in CD18 integrins appear to serve 
as a way for neutrophils to restrict their adhesive capacity. As such, a major consequence 
of CD18 integrin conformational shifts may be the minimization of neutrophil adhesion. 
Overall, the collective evidence for neutrophil mechanosensitive receptors, such as FPR 
and CD18, points to a link between neutrophil shear sensitivity and the expression of these 
membrane mechanoreceptors. 
 
2.5.3 The cell membrane is involved in the regulation of neutrophil mechanosensitivity 
 Since the cell membrane acts as the substrate for all transmembrane 
mechanosensitive proteins, it is conceivable that the mechanical properties of the cell 
membrane may also be capable of regulating neutrophil responsiveness to FSS. In 
particular, the fluidity of the cell membrane may affect mechanosensitivity by impacting 
the shear-related structural activity of transmembrane mechanoreceptors.  
Membrane fluidity is a measure of the lipid bilayer microviscosity, which 
influences the motion and conformational activity of the other phospholipids and resident 
signaling molecules such as cell surface protein receptors. Membrane fluidity changes may 
alter the dynamics of membrane protein activity by affecting their intermolecular actions 
or structural activity. In fact, changes in the membrane fluidity of cells have been reported 
to influence the number, affinity, lateral mobility, and conformational activity of 
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membrane receptors [98-101]. These physiological changes in membrane fluidity may 
arise, in part, due to the actions of cholesterol on the cell membrane (Fig. 2.4) 
 
Cholesterol is a regulator of membrane fluidity [102] capable of affecting 
neutrophil mechanosensitivity by altering the fluidity of the cell membrane. When 
extracellular cholesterol is integrated into the membrane, it causes the membrane to 
become more rigid and less fluid [103,104]. This has consequences for processes that 
depend on the fluidity of the cell membrane. For example, membrane cholesterol has been 
shown to disrupt the signaling of lipid rafts that regulate various neutrophil functions (e.g., 
chemotaxis/migration, adhesion, etc.) [105]. Furthermore, conformation-dependent 
receptors, such as GPCRs, reportedly display altered structural activity in response to 
ligand binding when cellular membrane fluidity is altered [88]. This suggests that, similar 
Figure 2.4. Mechanisms by which membrane cholesterol enrichment may impair 
neutrophil fluid shear stress mechanotransduction. 
Pathologic cholesterol elevations can lead to the enrichment of neutrophil membranes with 
cholesterol. This may alter neutrophil mechanosensitivity by affecting the ability of membrane 
receptors to response to shear. Alternatively, membrane cholesterol enrichment may interfere 
with the ability of neutrophils to release lysosomal proteases (such as ctsB) under shear. 
23 
to GPCRs, neutrophil FSS mechanosensors may have difficulty adopting changes in 
conformation under shear exposure due to membrane fluidity changes (Fig. 2.4). 
In addition to affecting the conformational activity and signaling of 
mechanosensitive receptors, cholesterol-related changes in membrane fluidity may also 
impair the release of bioactive molecules produced within the neutrophil. In support of this, 
membrane stiffening has been demonstrated to interfere with the release of pro-
inflammatory cytokines into the extracellular milieu [106]. This suggests that the 
transmembrane release of ctsB, which is required to cleave CD18 integrins, may be 
prevented by membrane fluidity changes associated with cholesterol enrichment (Fig. 2.4). 
Taken together, it is conceivable that the actions of hypercholesterolemia on the 
neutrophil membrane interfere with a critical regulatory mechanism (i.e., FSS 
mechanotransduction) charged with ensuring neutrophils remain inactivated.  In doing so, 
this may lead to the neutrophils becoming more adhesive, resulting in their sustained 
retention in the microvasculature with a detrimental impact on the microcirculation. This 
possibility is the focus of the investigations in the present dissertation. 
 
2.6 Study Rationale 
Recently, our lab reported neutrophil mechanosensitivity to be a function of the 
cholesterol-related fluidity of the cell membrane [27]. We also determined that cholesterol-
related impairment of FSS-induced pseudopod retraction was correlated with tissue blood 
flow dysregulation in hypercholesterolemic mice [26]. However, the pathogenic 
mechanism that connects impaired FSS sensitivity, neutrophil dysregulation, and 
microvascular dysfunction due to hypercholesterolemia remains to be determined. 
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  The present study explored a new pathogenic mechanism by focusing on how 
membrane fluidity changes may affect the FSS mechanoregulation of CD18 integrin 
expression. In doing so, the present study sought to not only determine how ctsB-induced 
CD18 cleavage regulated neutrophil adhesion to vascular endothelium, but also examine 
how membrane cholesterol enrichment may impair FSS mechanotransduction and whether 
it may serve as a potential mechanistic link between dysregulated neutrophil adhesion and 
microvascular dysfunction, two key features of hypercholesterolemia. 
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CHAPTER 3: CHARACTERIZATION OF THE FLUID SHEAR STRESS-
INDUCED CLEAVAGE OF CD18 INTEGRINS BY CATHEPSIN B RELEASE 
FROM NEUTROPHIL-LIKE CELLS 
 Neutrophils proteolytically shed the extracellular domains of surface-associated 
CD18 integrins when exposed to FSS under physiologic conditions [23,59,93]. This occurs 
through FSS-induced release of the cysteine protease ctsB, which targets CD18 in the 
ectodomain. However, it is not known which of the CD18 integrin heterodimers (i.e., either 
LFA1, Mac1, CD11c/CD18, or CD11d/CD18) is cleaved by ctsB.  
The present study sought to elucidate further mechanistic insight regarding the role 
of ctsB in the FSS regulation of CD18 integrin surface expression by neutrophils. Since all 
of the possible CD18-containing integrins have different roles during leukocyte 
recruitment and adhesion to the endothelium, the integrin specificity of ctsB was expected 
to provide a clue as to how FSS-induced CD18 cleavage deactivated the cell. 
The present study also sought to verify whether FSS mechanotransduction is a 
characteristic of the neutrophilic phenotype. HL60-derived neutrophil-like cells (dHL60-
NCs) have been used to model neutrophil migration and chemotaxis [107]. Furthermore, 
dHL60-NCs also exhibit shear sensitivity, as these cells retract pseudopods when exposed 
to FSS [92,108]. The studies outlined in this section focused on characterizing and 
verifying that, in response to FSS exposure, dHL60-NCs release ctsB and cleave CD18 
integrins similar to primary human neutrophils. The CD18 integrin cleavage responses of 
human neutrophils and dHL60 cells were compared to also determine if dHL60 cells would 
serve as a suitable transfection culture model for planned studies. 
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 We exposed human neutrophils and dHL60-NCs to shear using a cone-and-plate 
viscometer. Using both cells, we analyzed the FSS-induced cleavage response for LFA1 
and Mac1 in the presence of protease inhibitors. Additionally, we also analyzed the 
expression of CD11c on dHL60-NCs. Since dHL60-NCs upregulate CD11a and CD11b 
after differentiation [109], we wanted to ensure that other CD18 heterodimers were not 
being upregulated as well. We excluded CD11d from our analyses, as prior studies 
indicated that expression of this integrin is primarily limited to macrophages [110,111]. 
Finally, we stimulated cells with different concentrations of fMLP to determine whether 
inflammatory stimulation overrides FSS-induced CD18 cleavage. 
 
3.1 Methods 
3.1.1 Cells 
3.1.1a Human neutrophils 
Human subject recruitment, informed consent, and phlebotomy were approved by 
the University of Kentucky Institutional Review Board. Blood samples were harvested 
from asymptomatic human volunteers into K2-EDTA-coated vacutainers (Becton-
Dickinson) by standard venipuncture, as reported [27]. Neutrophils were then isolated by 
two-step Histopaque-Percoll gradient centrifugation and resuspended in Hank’s balanced 
salt solution (HBSS) containing calcium and magnesium, as reported [93]. These purified 
cell suspensions were estimated to contain >90% neutrophils. 
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3.1.1b HL60-derived neutrophilic cells 
HL60 cells (CCL-240; ATCC) were cultured in RPMI-1640 media (Invitrogen) 
supplemented with 10% fetal bovine serum (FBS; Hyclone) and 1% 
penicillin/streptomycin/L-glutamine (PSG; Mediatech) under standard incubation 
conditions (i.e., a humidified, 5% CO2/95% air environment maintained at 37°C) according 
to the manufacturer’s instructions. To induce a neutrophilic phenotype, HL60 cells (1x106 
cells/mL) were differentiated in neutrophilic induction media consisting of RPMI-1640 
media supplemented with 10% FBS, 1% PSG, and 1.25% dimethyl sulfoxide (DMSO; 
Sigma-Aldrich). HL60 differentiation proceeded over a period of 5 days as reported 
[92,108], with fresh neutrophilic induction media being replaced after 3 days. After HL60 
cells were completely differentiated into dHL60-NCs, the cells were washed twice in PBS 
and then allowed to recover in DMSO-free culture medium for 1 hour prior to their use.  
 
3.1.2 Cone-and-plate shear exposure 
A custom cone-and-plate viscometer with a cone angle of 1° was used to expose 
aliquots (1 mL) of human neutrophils or dHL60-NCs to a constant laminar shear stress 
field of 5 dyn/cm2 for 10 minutes as previously reported [27]. To achieve the desired shear 
stress of 5 dyn/cm2 while assuming a viscosity of ~0.01 P, the cone was set to rotate at a 
rate of 82 rpm over a 10 minute period (Fig. 3.1). This was determined by using the 
following equation to calculate the shear stress applied by the cone-and-plate viscometer: 
𝜏𝜏 =
𝜇𝜇 × 2𝜋𝜋𝜋𝜋
60 sin𝜃𝜃
 
where τ is shear stress (dyn/cm2), μ is viscosity (P), ω is the rotational rate of the cone 
(rpm), and θ is the angle of the cone (degrees). 
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Additional chemical treatments were performed on cells prior to, or during, shear 
exposure to test the involvement of the mechanisms of interest regarding FSS-induced 
CD18 cleavage. For experiments conducted with protease inhibitors, human neutrophils 
were pretreated with and without 30 µM E64 (cysteine protease inhibitor), 50 µM CA074-
me (ctsB inhibitor) or 5 µM aprotinin (AP; negative control inhibitor) for 5 minutes prior 
to shear exposure as reported [112]. Similarly, dHL60-NCs were pretreated with 30 μM 
E64, 5 μM aprotinin, or 1 μM pepstatin (aspartyl protease inhibitor) for 5 minutes, or 50 
mM doxycycline (MMP inhibitor) for 30 minutes. For experiments conducted with 
inflammatory agonists, human neutrophils and dHL60-NCs were pretreated with or 
without 0.01 – 10 μM fMLP for 10 minutes. 
Once human neutrophils or dHL60-NCs were pretreated for the appropriate 
duration of time, the cells were kept in HBSS with the inhibitory reagents and exposed to 
shear using the cone-and-plate viscometer. Controls were parallel cell populations 
maintained under static (i.e., no-FSS), but otherwise similar experimental, conditions. In 
this case, the cone was held stationary while cells were allowed to incubate on the plate. 
Figure 3.1. Representative diagram of a cone-and-plate viscometer. 
By using a cone-and-plate viscometer, cell suspensions can be exposed to a uniform shear 
stress. The applied shear stress depends on the shallow cone angle, rotational rate, and 
viscosity of the solution. 
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Immediately after shear and control experiments, cells were fixed (1% p-formaldehyde in 
phosphate buffer) for 15 minutes. After fixation, cell populations were washed three times 
in PBS and prepared for immunofluorescence. 
 
3.1.3 Immunofluorescence 
Fixed human neutrophils or dHL60-NCs were resuspended in 1% bovine serum 
albumin (BSA) in PBS for 30 minutes and subsequently labeled with fluorescent antibodies 
for one hour using standard immunochemistry. Some cell populations were left 
unpermeabilized to assess surface expression, while other cell populations were 
permeabilized to assess intracellular expression by adding 0.1% saponin to the 1% BSA 
buffer prior to fluorescent antibody labeling. After fluorescent labeling, cell suspensions 
were washed three times in PBS to remove unbound antibodies and subsequently 
resuspended in PBS for flow cytometric analyses. 
For analysis of surface integrin expression on human neutrophils and dHL60-NCs, 
FITC-conjugated mouse monoclonal antibody (mAb) to CD18 (clone 6.7), PE-conjugated 
mouse mAb to CD11a (clone 38), or Alexa Fluor 488-conjugated mouse mAb to CD11b 
(clone ICRF44) were used to label unpermeabilized cells as reported [59]. Some dHL60-
NCs were also labeled with FITC-conjugated mouse mAb to CD11c (clone B-ly6). For 
analysis of total cellular CD18 levels (i.e., cleaved and uncleaved integrins), permeabilized 
dHL60-NCs were labeled with goat polyclonal antibody (pAb) against the intracellular 
domain for CD18 (clone C-20) in conjunction with an Alexa Fluor 488-conjugated donkey 
anti-goat IgG (i.e., secondary) antibody (Invitrogen). Nonspecific binding was quantified 
using an Alexa Fluor 488-conjugated mouse IgG1 isotype control (Invitrogen). 
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 For analysis of ctsB expression in human neutrophils and dHL60-NCs, cells were 
labeled with rabbit pAb (clone Ab-3) in conjunction with an Alexa Fluor 488-conjugated 
goat anti-rabbit IgG (i.e., secondary) antibody (2 mg/mL; Invitrogen). Cells were left 
unpermeabilized to assess surface ctsB expression, while some cells were permeabilized 
using 0.1% saponin to assess total ctsB expression. Nonspecific binding was quantified 
using an Alexa Fluor 488-conjugated mouse IgG1 (Invitrogen) and an Alexa Fluor 488-
conjugated goat IgG1 (Santa Cruz Biotechnology). 
 
3.1.4 Flow cytometry 
Flow cytometric analyses utilized an LSR II flow cytometer (Becton-Dickinson) 
interfaced with Becton-Dickinson FACsDiva software, as previously reported [59]. 
Neutrophil and dHL60-NC populations were gated based on their forward scatter (FSC) 
and side scatter (SSC) values. The total fluorescence intensity, representing the amount of 
bound antibodies, was used as the measure of antigen specific expression level. By using 
the total fluorescence intensity, histograms of antigen-specific fluorescence intensity were 
generated for each sample using the FCS Express 4 Flow Cytometry software (De Novo 
Software). Shear-induced changes in the antigen expression levels were normalized to 
those of their respective controls and expressed as “fold change”. 
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3.1.5 Statistics 
Quantitative data derived from dHL60-NCs and human neutrophils were expressed 
as mean ± standard error of the mean (SEM) for n ≥ 3 replicates. Statistical analyses were 
performed using the statistical software program JMP (SAS Institute). One-sample t-tests 
with P < 0.05 were used to identify significant fold changes or percent reductions in 
experimental treatments compared to a reference value. Comparisons between the means 
of experimental treatments (i.e. unstimulated cells vs. chemically-pretreated cells) were 
performed using ANOVA and post-hoc Tukey’s test with P < 0.05 indicating significance. 
 
3.2 Results 
3.2.1 Fluid shear stress-induced cathepsin B release selectively cleaves Mac1 in human 
neutrophils 
  Human neutrophils left untreated (UNT) and exposed to FSS (5 dyn/cm2 for 10 
min) with a cone-plate device exhibited reduced binding of antigen-specific antibodies to 
CD18 and CD11b, but not CD11a integrins relative to time-matched, unsheared controls 
(Fig. 3.2, A – C). This reduction in CD18 antibody binding was blocked for cells pretreated 
with CA074, but not AP (our negative control protease), prior to shearing (Fig. 3.2, D). 
CA074 and AP had no effect on binding of CD11a antibodies to neutrophils after control 
or FSS experiments (Fig. 3.2, E). Notably, FSS-induced reductions in CD11b antibody 
binding to neutrophils were mitigated by CA074, but not by AP (Fig. 3.2, F). 
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3.2.2 Fluid shear stress induces time-dependent cathepsin B release by human neutrophils 
  Permeabilized human neutrophils exhibited significantly reduced binding to ctsB 
antibodies after 2.5 min of FSS exposure when compared to unsheared cells (Fig. 3.3, A). 
This apparent reduction in total ctsB levels was observed for the duration of the 10 min 
exposure (Fig. 3.3, C). In contrast, ctsB antibody binding to unpermeabilized human 
Figure 3.2. The selective cleavage of Mac1 by shear-induced cathepsin B release. 
(A-C) Representative flow cytometry histograms depicting the fluorescent intensity of intact 
CD18 (A), CD11a (B), and CD11b (C) expressed on the surface of neutrophil suspensions 
maintained under no-flow conditions (thick black line) or subjected to 5 dyn/cm2 shear stress 
(hatched shading) using a cone-and-plate viscometer. A negative (IgG) staining control is also 
displayed in each plot (dark gray shading). Neutrophil suspensions were treated with or 
without ctsB-specific inhibitor CA074 (50 µM) and serine inhibitor aprotinin (AP; 5 µM). (D-
F) Based on florescent antibody binding, mean fluorescent intensities of sheared neutrophils 
were normalized to their respective no-flow controls and plotted as fold change ± SD for 
CD18 (D), CD11a (E), and CD11b (F) integrins. n = 3 replicates in each group. *P < 0.05 
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to control. 
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neutrophils remained unchanged after 2.5 and 10 min of FSS exposure (Fig. 3.3, B). While 
surface-associated ctsB appeared to be significantly elevated after 5 min of FSS, the 
differences in expression levels were minor (Fig. 3.3, D).  
 
3.2.3 Exposure to shear induces CD18 cleavage in dHL60-NCs 
DHL60-NCs expressed intact CD18 integrins on their surfaces under all conditions 
tested in the present study (Fig. 3.4, A) as indicated by their binding affinity to mAb 6.7 
relative to that of mouse IgG (negative staining control). Notably, untreated dHL60-NC 
Figure 3.3. Fluid shear stress induces time-dependent cathepsin B release. 
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB 
expression within the cytosolic domain (A) or membrane surface domain (B) for neutrophil 
suspensions maintained under no-flow conditions (thick black line) or exposed to 5 dyn/cm2 
shear stress (hatched shading) using a cone-and-plate viscometer. A negative (IgG) staining 
control is also displayed in each plot (dark gray shading). Shear duration was gradually 
increased (2.5, 5, and 10 minutes) to observe the time-dependent effects of shear. (C-D) Based 
on fluorescent antibody binding, mean fluorescence intensities of sheared neutrophils were 
normalized to their respective no-flow controls and plotted as fold change ± SD for ctsB 
cytosolic (C) or membrane surface (D) expression. n = 3 replicates in each group. *P < 0.05 
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 2.5 minute 
shear exposure. ^P < 0.05 compared to 10 minute shear exposure. 
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populations exposed to 5 dyn/cm2 FSS, in the absence or presence of 0.01 μM fMLP, 
exhibited significantly (P < 0.05) reduced binding of mAb 6.7 relative to cells maintained 
under control (i.e., no-flow), but otherwise similar experimental, conditions. The FSS-
induced reductions in cell surface affinity to mAb 6.7 were abrogated when untreated or 
fMLP-stimulated dHL60-NCs were pretreated and subsequently exposed to shear with the 
cysteine protease inhibitor E64. In this case, no noticeable shift in fluorescent intensity 
(indicative of mAb 6.7 binding) was observed between sheared and unsheared samples 
when the cells were in the presence of E64 (Fig. 3.4, B). 
 
Figure 3.4. Fluid shear stress promotes cleavage of CD18 integrins off the surface of 
dHL60-NCs. 
(A) Representative flow cytometry histograms depicting the fluorescent intensity of CD18 
expression on the surface of dHL60-NC suspensions maintained under no-flow conditions 
(blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a cone-and-plate viscometer. 
A negative (IgG) staining control is also displayed in each plot (hatched shading). DHL60-NC 
suspensions were treated with or without fMLP (0.01 µM) and cysteine inhibitor E64 (30 
µM). (B-C) Based on fluorescent antibody binding, mean fluorescence intensities of sheared 
neutrophils were normalized to their respective no-flow controls and plotted as fold change ± 
SEM for CD18 membrane surface (C) or cytosolic (D) expression. n = 4 replicates in each 
group. *P < 0.05 compared to a normalized control value of 1 (dotted line). #P < 0.05 
compared to control. 
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Untreated dHL60-NC populations exposed to FSS, whether in the absence or 
presence of 0.01 µM fMLP, did not exhibit reductions in the binding of pAb C-20 antibody 
against the cytoplasmic domains of CD18 integrins (Fig. 3.4, C). Similarly, untreated or 
fMLP-stimulated dHL60-NCs that were pretreated with E64 also did not exhibit a 
reduction in affinity to pAb C-20 when exposed to FSS. In both cases, the cytoplasmic 
CD18 integrin expression by dHL60-NCs exposed to FSS remained similar to that 
expressed by dHL60-NCs maintained under control (i.e., no-flow), but otherwise similar 
experimental, conditions. Combined, these results provided evidence that shear exposure 
promotes cleavage of CD18 integrins in the extracellular domain. 
 
3.2.4 Exposure to shear induces CD11a, but not CD11b, cleavage in dHL60-NCs 
Under all conditions tested in the present study, dHL60-NCs displayed detectable 
surface expression levels of intact CD11a (Fig. 3.5, A) and intact CD11b (Fig. 3.5, B) 
integrins. Specifically, all fluorescent intensities indicative of integrin subtype-specific 
antibody binding were greater than those of cells stained with isotype-matched mouse IgG 
negative control proteins. 
Notably, the surfaces of dHL60-NCs exposed to FSS, in the absence or presence of 
fMLP, exhibited reduced binding to mAb 38 antibodies indicative of significant (P < 0.05) 
reductions in surface expression of intact CD11a relative to time-matched, unsheared 
controls. This FSS-induced reduction in surface affinity for mAb 38 antibodies was 
attenuated, but not completely blocked, by treatment of either untreated or fMLP-treated 
cells with E64 prior to and during flow experiments (Fig. 3.5, C).  
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In contrast, untreated and fMLP-treated dHL60-NCs either maintained under 
control conditions or exposed to FSS exhibited similar binding affinities for mAb ICRF44 
directed against the extracellular domain of CD11b (Fig. 3.5, D). Similarly, untreated or 
fMLP-stimulated dHL60-NCs that were pretreated with E64 and either maintained under 
control conditions or exposed to FSS also exhibited similar binding affinities for mAb 
ICRF44 against CD11b. Thus, FSS exposure induced cleavage of CD11a, but not CD11b, 
integrins by dHL60-NCs. 
 
 
Figure 3.5. Fluid shear stress reduces surface expression of CD11a, but not CD11b, on 
dHL60-NCs. 
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of CD11a 
(A) and CD11b (B) expression on the surface of dHL60-NC suspensions maintained under 
no-flow conditions (blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a cone-
and-plate viscometer. A negative (IgG) staining control is also displayed in each plot (hatched 
shading). DHL60-NC suspensions were treated with or without fMLP (0.01 µM) and cysteine 
inhibitor E64 (30 µM). (C-D) Based on fluorescent antibody binding, mean fluorescence 
intensities of sheared dHL60-NCs were normalized to their respective no-flow controls and 
plotted as fold change ± SEM for CD11a (C) or CD11b (D) expression. n = 4 replicates in 
each group. *P < 0.05 compared to a normalized control value of 1 (dotted line). #P < 0.05 
compared to control + 30 µM E64. 
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3.2.5 DHL60-NCs do not express the CD11c integrin on their surface 
DHL60-NCs are capable of upregulating their expression of CD11a and CD11b 
integrins during differentiation [109]. We wanted to ensure that other CD18 heterodimers, 
such as CD11c, were not expressed on dHL60-NCs. As such, we investigated the 
possibility that CD11c/CD18 integrins were cleaved by dHL60-NCs in response to shear 
exposure. However, our analyses revealed that dHL60-NCs, either maintained under 
control conditions or exposed to FSS, did not exhibit detectable surface expression of 
CD11c integrins. Specifically, there was no detectable difference in the surface binding 
affinity of unsheared and sheared dHL60-NCs to either mAb B-Ly6 or mIgG negative 
staining control protein (Fig. 3.6, A). Moreover, treatment of cells with fMLP and/or E64, 
both with or without FSS exposure, had no effect on the membrane surface expression 
levels of CD11c integrins (Fig. 3.6, B). 
 
Figure 3.6. DHL60-NCs do not express the CD11c integrin. 
(A) Representative flow cytometry histogram depicting the fluorescent intensity of CD11c 
expression on the surface of dHL60-NC suspensions maintained under no-flow conditions 
(blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a cone-and-plate viscometer. 
A negative (IgG) staining control is also displayed in each plot (hatched shading). DHL60-NC 
suspensions were treated with or without fMLP (0.01 µM) and cysteine inhibitor E64 (30 
µM). (B) The mean fluorescence intensities used to quantify binding of mAb B-ly6 to dHL60-
NCs were plotted as CD11c expression level ± SEM. n = 3 replicates in each group. 
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3.2.6 DHL60-NCs display minimal expression of cathepsin B 
In comparison to human neutrophils, dHL60-NCs displayed low to minimal surface 
and cytosolic levels of ctsB (Fig. 3.7, A – B). On average, human neutrophils displayed 
binding affinities to pAb Ab-3 that were significantly greater than that of the secondary 
Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody alone, both on their cell surface 
as well as within their cytoplasm (Fig. 3.7, C). In contrast, the binding affinities of dHL60-
NCs to pAb Ab-3, either on the cell surface or within the cytoplasm, were comparable to 
their binding affinities to the secondary antibody alone (Fig. 3.7, D). 
Figure 3.7. Human neutrophils, but not dHL60-NCs, express cathepsin B. 
(A-B) Representative flow cytometry histogram depicting the fluorescent intensity of ctsB 
expression on the surface of human neutrophil (A) or dHL60-NC (B) suspensions maintained 
under no-flow conditions (blue line) or exposed to 5 dyn/cm2 shear stress (red line) using a 
cone-and-plate viscometer. A negative (IgG) staining control is also displayed in each plot 
(hatched shading). (C-D) Based on fluorescent antibody binding, mean fluorescence 
intensities of sheared cells were normalized to their respective no-flow controls and plotted as 
ctsB expression level ± SEM for human neutrophils (C) or dHL60-NCs (D). n = 3 replicates 
in each group. *P < 0.05 compared to secondary antibody. 
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3.2.7 Shear-induced CD11a/CD18 cleavage may involve multiple proteases, including 
cysteine proteases, for dHL60-NCs 
 DHL60-NCs treated with serine and aspartyl protease inhibitors (aprotinin and 
pepstatin, respectively) prior to, and during, FSS exposure exhibited significant reductions 
in binding affinities for antibodies directed against the extracellular domains of CD18 and 
CD11a, relative to their respective time-matched, unsheared controls (Fig. 3.8, A – B). 
Notably, while doxycycline completely inhibited FSS-induced reductions in dHL60 
binding to mAb 6.7 against CD18, it only partially blocked FSS-induced reductions in 
binding to mAb 38 against CD11a. This same pattern of blocking was observed for E64. 
Thus, the reduced surface expression of intact CD11a and CD18 integrins by dHL60-NCs 
exposed to shear occurred independently of aspartyl, serine, and MMP-9 proteases. This 
implicates a cysteine protease in the FSS-induced reductions of CD11a. 
 
Figure 3.8. Fluid shear stress-induced reductions in CD18 and CD11a surface expression 
involve cysteine proteases for dHL60-NCs. 
(A-B) Mean fluorescence intensities (MFI) used to quantify reductions in CD18 (A) or CD11a 
(B) expression by dHL60-NCs after exposure to 5 dyn/cm2 shear stress in the absence 
(control; white bars) or presence (black bars) of protease inhibitors were normalized to their 
respective controls and plotted as average fold change ± SEM. The following protease 
inhibitors were tested: 5 μM aprotinin (AP), 1 μM pepstatin (PEP), 30 μM E64 (cysteine 
inhibitor), or 50 mM doxycycline (DOX). n = 3 replicates in each group. *P < 0.05 compared 
to a normalized control value of 1 (dotted line). #P < 0.05 compared to E64. ^P < 0.05 
compared to DOX. 
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3.2.8 Cell agonist fMLP dose-dependently suppresses shear-induced cleavage of CD18 
integrins in neutrophil-like cells 
Untreated dHL60-NCs, as well as cells stimulated with 0.01 µM fMLP, exhibited 
significant reductions in CD18 surface expression in response to FSS exposure. However, 
this response was attenuated, and completely blocked, when stimulated with 1 and 10 µM 
fMLP, respectively (Fig. 3.9, A). Additionally, CD11a surface expression by dHL60-NCs 
was significantly reduced after exposure to FSS under all concentrations of fMLP tested 
(Fig. 3.9, B). The post-shear reduction in CD11a surface expression, however, was 
attenuated at higher fMLP concentrations (1 and 10 µM). 
Similarly to dHL60-NCs, untreated human neutrophils, as well as human 
neutrophils stimulated with 0.01 µM fMLP, exhibited significant reductions in CD18 
surface expression in response to FSS. However, this response was attenuated, and 
completely blocked, when stimulated with 1 and 10 µM fMLP, respectively (Fig. 3.9, C). 
In the case of the CD11 subunits, CD11b surface expression by human neutrophils was 
significantly reduced after exposure to FSS in the presence of 0 – 0.01 µM fMLP (Fig. 3.9, 
D). The post-shear reduction in CD11b surface expression, however, was attenuated at 
higher fMLP concentrations (1 and 10 µM). These results suggest that high levels of 
inflammatory agonists may be capable of overriding the FSS-induced cleavage of CD18 
and CD11 integrins. 
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3.2.9 Summary of findings/interpretations 
The results of the present study provided evidence for the following significant findings. 
• FSS-induced CD18 cleavage is characteristic of neutrophil-like cells, which 
suggests this is a key mechanoregulatory control mechanism for neutrophils. 
• FSS-induced release of ctsB selectively cleaves Mac1, suggesting FSS 
mechanotransduction serves to restrict firm neutrophil adhesion. 
Figure 3.9. The inflammatory agonist fMLP dose-dependently attenuates shear-induced 
CD18 cleavage in neutrophil-like cells. 
(A-B) Mean fluorescence intensities (MFI) used to quantify reductions in CD18 (A) or CD11a 
(B) expression by dHL60-NCs after exposure to 5 dyn/cm2 shear stress in the absence 
(control; white bars) or presence (black bars) of fMLP were normalized to their respective 
controls and plotted as average fold change ± SEM. FMLP was used at 0, 0.01, 1, and 10 μM 
concentrations. (C-D) Mean fluorescence intensities (MFI) used to quantify reductions in 
CD18 (C) or CD11b (D) expression by human neutrophils after exposure to 5 dyn/cm2 shear 
stress in the absence (control; white bars) or presence (black bars) of fMLP were normalized 
to their respective controls and plotted as average fold change ± SEM. FMLP was used at 0, 
0.01, 1, and 10 μM concentrations.  n = 3 replicates in each group. *P < 0.05 compared to a 
normalized control value of 1 (dotted line). #P < 0.05 compared to 10 μM fMLP. ^P < 0.05 
compared to 1 μM fMLP. 
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• FSS-induced CD18 cleavage appears to be anti-inflammatory and can be 
overridden by high levels of inflammatory agonists. 
• FSS-induced CD18 cleavage is a characteristic response of neutrophil-like cells to 
FSS exposure. 
• The dHL60-NC culture model may be used as a transfectable cell line for the 
purpose of mechanistic-based explorations of FSS mechanotransduction for 
neutrophils. 
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CHAPTER 4: EVALUATING THE ROLE OF FLUID SHEAR-INDUCED 
CATHEPSIN B RELEASE IN THE CONTROL OF MAC1-DEPENDENT 
NEUTROPHIL ADHESION 
Because our previous experiments established a role for ctsB in the cleavage of 
Mac1 under FSS exposure, we wanted to investigate the possibility that this protease 
regulates Mac1-related neutrophil adhesive processes. In vivo, neutrophils firmly adhere to 
platelets, other leukocytes, and endothelium using Mac1 [12,113,114]. Expression of Mac1 
is important, as Mac1-knockout mice are associated with neutrophils that exhibit a 
markedly reduced adhesive capability, particularly during inflammation [115,116]. 
Additionally, Mac1-deficient neutrophils exhibit reduced migration rates [117]. Because 
neutrophil migration involves the projection and retraction of pseudopods which utilize 
Mac1 for stabilization [117], we sought to determine how ctsB could modulate Mac1-
dependent neutrophil pseudopod activity during migration under no-flow conditions. We 
did so using exogenous ctsB or ctsB inhibitors as well as dHL60-NCs overexpressing ctsB. 
Mac1 integrins are also critical for the arrest/firm adhesion of neutrophils to 
microvasculature under flow conditions [118,119]. Since Mac1 is cleaved under FSS 
exposure by ctsB release, the experiments in the present study sought to determine how 
FSS mechanotransduction played a role in the control of Mac1-dependent neutrophil 
adhesion under flow. To accomplish this, we allowed neutrophils to adhere to platelet and 
endothelial cell monolayers and exposed them to flow to monitor their detachment as an in 
vitro test of the FSS regulation of neutrophil adhesion. By pretreating neutrophils with ctsB 
inhibitors, we could evaluate the importance of ctsB in regulating neutrophil adhesion 
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under these flow conditions. Collectively, the goal of the studies described in this chapter 
was to evaluate the role of ctsB in the control of neutrophil adhesive capacity. 
 
4.1 Methods 
4.1.1 Cells 
4.1.1a Human neutrophils and platelets 
  Human neutrophils were purified from whole blood harvested from asymptomatic 
volunteers as described in section 3.1.1a. Approximately 5 mL of whole blood was also set 
aside to purify platelets for use in flow-based detachment assays (see section 4.1.3) that 
were used to quantify the ability of FSS to restrict neutrophil adhesion. Platelets were 
extracted from plasma by removing erythrocytes and leukocytes through low speed 
(100xg) centrifugation, washing the supernatant solution in HEPES buffer, and suspending 
the platelets in Tyrode’s buffer, according to detailed procedures [120]. 
 
4.1.1b Human cell culture 
  HL60 cells were cultured as previously described in section 3.1.1b. Differentiation 
of HL60 cells into dHL60-NCs also occurred as previously described in section 3.1.1b. On 
day 4 of differentiation, however, dHL60-NCs were transiently transfected with a ctsB-
green fluorescent protein (ctsB-GFP) expression vector. Transfections were carried out 
using a Lonza Nucleofector Electroporator with the preset program T-019 and following 
the manufacturer’s instructions. After transfection, dHL60-NCs were cultured in 
neutrophilic induction media for the remaining fifth day. 
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  Human umbilical vein endothelial cells (HUVECs; Lifeline Cell Technology) were 
cultured in VascuLife VEGF media (Lifeline Cell Technology) supplemented with 10% 
FBS and 1% PSG, according to the manufacturer’s instructions. The HUVECs were grown 
under standard incubation conditions described in section 3.1.1b. HUVECs were passaged 
approximately every three days to maintain optimal growth. These cells were used for 
flow-based cell detachment assays (see section 4.1.3) to quantify FSS regulation of 
neutrophil adhesion. 
 
4.1.2 Pseudopod activity analysis 
  Glass slides were cleaned prior to experimentation using separate incubations in 
acetone and 70% ethanol in an ultrasonic cleaner for 15 minutes each. The glass substrates 
were then treated with 1 N NaOH for 2 hours to generate a hydrophobic surface conducive 
for cell adhesion and then pre-coated with fetal bovine serum for 10 minutes. For 
experiments, neutrophils and dHL60-NCs were pretreated for 5 min with and without 1 
μM fMLP, 0.5 U/mL ctsB, or 50 µM CA074 and then deposited (at a density of 1x106/mL) 
on the FBS-coated glass slides for 20 min. Non-adherent cells were rinsed with PBS, and 
the remaining adherent cells were maintained under no-flow conditions in HBSS. Bright 
field micrographs of neutrophils, as well as bright field and fluorescence images of ctsB-
GFP transfected cells, were acquired every 15 s for 10 min using an Olympus IX-71 
fluorescence microscope. 
  To calculate cell centroid displacement rates, ImageJ was used to manually trace 
individual cells and track the movement of their centroid between consecutive frames 
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[121]. The centroid displacement rate, calculated by the following equation, was used as a 
surrogate measure of dynamic cell shape changes due to pseudopod activity:  
Centroid displacement rate (CDR) =
�(x2 − x1)2 + (y2 − y1)2
t
 
where x1 is the initial x coordinate, x2 is the final x coordinate, y1 is the initial y coordinate, 
y2 is the final y coordinate, and t is the time between frames (Fig. 4.1, A). 
  To calculate the rates of pseudopod extension and retraction, ImageJ was used to 
analyze selected pseudopod projections (Fig. 4.1, B). First, the major axis length of a 
pseudopod projection was calculated. Then, the duration of time it took for the pseudopod 
to achieve this length was measured over several consecutive frames. For pseudopod 
projection, the initial time point was determined to be when a pseudopod emerged from 
Figure 4.1. Representative images of centroid displacement and pseudopod projection 
analyses. 
(A) The rate of cell migration was calculated as the rate of centroid displacement. The black 
solid arrow represents the migration path of a neutrophil over a specific duration of time. The 
red dashed arrow represents the centroid displacement rate (CDR) of the neutrophil over that 
same duration of time. (B) The rate of pseudopod projection or retraction was calculated by 
dividing the major axis length of a pseudopod by the interval of time necessary to achieve this 
length. The red arrow represents the major axis length of a pseudopod. 
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the cell membrane, and the final time point was estimated to be when the same pseudopod 
achieved its major axis length. For pseudopod retraction, the initial time point was when 
the pseudopod was at its major axis length, and ended once the pseudopod had fully 
retracted. The corresponding rate of projection or retraction was then calculated by dividing 
the maximum pseudopod length by the duration of time. 
 
4.1.3 Neutrophil detachment assay 
  Detachment assays were conducted using autologous human platelets that had been 
deposited on cleaned glass slides (described in section 4.1.2) and allowed to spread into a 
uniform coating for 30 min following previously-reported procedures [122]. A flow 
channel was assembled by interfacing the platelet-coated slides to a polycarbonate base 
having inlet and outlet ports (Fig. 4.2). A pre-cut gasket separating these two components 
formed a 200-µm high parallel plate flow channel. We selected a parallel plate flow 
chamber for experimental analyses to expose cells to a constant laminar shear stress over 
a given duration of time. This ensured that cell detachment under FSS exposure would be 
due to mechanoregulatory processes at our defined shear stress magnitude. 
  Detachment assays were also conducted using HUVECs seeded (5 x 105/mL) and 
grown on fibronectin-coated culture surfaces of 17 (l) x 3.8 (w) mm Ibidi microslides 
(VI0.4; 400-µm high channel) for 3 days as reported [123]. The Ibidi microslides offered a 
sterile culture environment to grow HUVEC monolayers to confluency, and have been 
used in previous flow-based assays to maintain sterility [123,124]. Furthermore, the 
dimensions of the Ibidi microslides enabled us to achieve the same shear stress magnitude 
as our custom parallel plate flow system. 
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  For flow studies, neutrophils (5x106/mL) were pretreated with and without 1 µM 
fMLP, 30 µM E64, 50 µM CA074-me, or 5 µM AP for 5 min and deposited on the platelet 
or HUVEC monolayers for 10 min, after which the non-adherent cells were rinsed away. 
A syringe pump was used to perfuse HBSS through the chamber to impose a FSS of 5 
dyn/cm2 on the wall of the channel. The flow rate was adjusted to impose 5 dyn/cm2 as 
calculated according to the following equation: 
Flow rate (𝑄𝑄) =
τwbh2
6µ
 
where τw is wall shear stress, b is the channel width, h is the channel height, and μ is the 
perfusate viscosity. Bright field micrographs (100X magnification) of the neutrophils were 
acquired every 5 s for 10 min, and neutrophil detachment was estimated by normalizing 
the number of neutrophils visible in each image against that present 30 seconds after flow 
initiation. We defined this initial time point to be t = 0 to ensure non-adherent cells were 
rinsed away prior to analyses. 
Figure 4.2. Schematic representation of the flow-based detachment assay. 
This diagram represents the flow-based detachment assay for platelet-coated glass slides. 
HBSS is perfused into the chamber using the syringe pump. 
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4.1.4 Statistics 
  Quantitative data derived using human blood-derived neutrophils and dHL60-NCs 
cells were expressed as mean ± standard deviation (SD) for n ≥ 3 replicates. Statistical 
analyses were performed using JMP software (SAS Institute). One-sample t-tests with P < 
0.05 were used to identify significant fold changes or percent reductions in experimental 
treatments compared to a reference value. Comparisons between the means of experimental 
treatments were performed using ANOVA and post-hoc Tukey’s test with P < 0.05 
indicating significant differences. 
 
4.2 Results 
4.2.1 Cathepsin B enhances human neutrophil pseudopod activity 
  Human neutrophils were treated with exogenous ctsB in order to determine how 
Mac1-dependent neutrophil migration may be affected by proteolytic cleavage. Compared 
to untreated human neutrophils, those treated with exogenous ctsB (Fig. 4.3, A) displayed 
significantly elevated cell centroid displacement rates consistent with increased pseudopod 
activity (Fig. 4.3, B). The observed ctsB-mediated increases in pseudopod activity were 
attenuated by CA074. Notably, ctsB stimulated a greater increase in pseudopod retraction 
rates (by 2 to 2.5 fold over untreated cells) than in pseudopod extension rates (by 
approximately 1.5 fold over untreated cells) (Fig. 4.3, C). CA074 attenuated the effects of 
ctsB. Combined, these data are consistent with ctsB enhancing the pseudopod activity of 
neutrophils, likely through an effect involving Mac1 cleavage during pseudopod retraction. 
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4.2.2 Cathepsin B enhances dHL60-NC pseudopod activity 
  To further assess the potential influence of ctsB on pseudopod activity, dHL60 
neutrophil-like cells were transiently transfected with ctsB-GFP expression plasmids. 
These cells displayed GFP fluorescence (Fig. 4.4, A), indicating that transfected cells were 
overexpressing ctsB-GFP. Cells transfected with empty vectors (EV) exhibited no GFP 
fluorescence (Fig. 4.4, B). The EV transfectants exhibited baseline cell centroid 
Figure 4.3. The influence of cathepsin B on neutrophil pseudopod activity. 
(A) Representative images of migrating neutrophils adhered to glass slides and maintained 
under no-flow conditions. Untreated neutrophils were quiescent and formed few pseudopods. 
CtsB-stimulated neutrophils rapidly formed and retracted many pseudopods, some of which 
are observed in the representative images. (B) Neutrophil migration was quantified as mean 
centroid displacement rate (MCDR) over a 15 seconds and plotted as mean ± SD, based on 
cell tracings performed using ImageJ software. Neutrophils were treated with or without 
exogenous ctsB (0.5 u/mL) and ctsB-specific inhibitor CA074 (5 µM). n = 3 replicates in each 
group. *P < 0.05 compared to control. #P < 0.05 compared to CA074. (C) Neutrophil 
pseudopod activity during migration was quantified as mean pseudopod displacement rate 
(MPDR) based on manual tracings of projecting (white bars) or retracting (gray bars) 
pseudopods using ImageJ software. Neutrophils were treated with or without exogenous ctsB 
(0.5 u/mL) and ctsB-specific inhibitor CA074 (5 µM). n = 3 replicates in each group. *P < 
0.05 compared to control (projection). ^P < 0.05 compared to control (retraction). #P < 0.05 
compared to CA074 (projection and retraction). Scale bars are 10 µm. 
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displacement rates (indicative of pseudopod activity levels), while those of ctsB-GFP 
transfectants were significantly (P < 0.05) higher (Fig. 4.4, C). CA074 mitigated the 
difference in pseudopod activity between these two populations. These data further support 
the ability of ctsB to enhance pseudopod activity. 
4.2.3 Fluid shear stress-induced human neutrophil detachment from substrates involves 
cathepsin B release 
  This experiment employed a flow-based cell detachment assay to evaluate the role 
of FSS in regulating Mac1-dependent neutrophil adhesivity. Untreated human neutrophils 
Figure 4.4. The influence of cathepsin B on dHL60-NC pseudopod activity. 
(A-B) Representative images of migrating dHL60s that were transiently transfected through 
electroporation with a ctsB-GFP expression vector (ctsB+) or an empty vector (EV) and 
maintained under no-flow conditions. (C) DHL60 migration was quantified as mean centroid 
displacement rate (MCDR) over a 15 second time interval and plotted as mean ± SD, based on 
cell tracings manually performed using ImageJ software. DHL60s transfectants (ctsB+ or EV) 
were treated with or without ctsB-specific inhibitor CA074 (5 µM). n = 3 replicates in each 
group. *P < 0.05 compared to control. #P < 0.05 compared to CA074. 
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pre-adhered to platelet monolayers exhibited time-dependent cell detachment over a 10 
min period of FSS exposure (Fig. 4.5, A – B). When human neutrophils were exposed to 
FSS in the presence of fMLP (above threshold levels known to block neutrophil shear 
responses [20,112]), little detachment from platelet monolayers was observed (Fig. 4.5, C). 
Blocking ctsB activity with either E64 or CA074-me also caused human neutrophils to 
largely remain adherent to platelet monolayers under FSS. In contrast, neutrophils 
pretreated with irreversible serine protease inhibitor, AP (negative control), detached from 
platelet layers under FSS exposure in a fashion similar to that of untreated cells.  
  Similarly, while untreated human neutrophils adhered to HUVEC monolayers 
exhibited time-dependent cell detachment upon acute exposure to FSS for 10 min, both 
fMLP (above threshold levels that impair the neutrophil shear responsiveness) and ctsB 
inhibitors, E64 or CA074-me, blocked this detachment response to FSS (Fig. 4.5, D). On 
the other hand, pretreatment of cells with AP had no effect on FSS-induced neutrophil 
detachment. These results implicated the ctsB activity in the FSS-induced regulation of 
neutrophil adhesion to substrates. 
 
4.2.4 Summary of findings/interpretations 
The results of the present study provided evidence for the following significant findings. 
• CtsB enhances neutrophil migration rates under no-flow conditions, likely through the 
cleavage of Mac1 integrins during the uropod retraction phase of neutrophil migration. 
• FSS-induced ctsB release serves to restrict neutrophil adhesion to biological substrates 
through the cleavage of Mac1 integrins under flow conditions. 
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• Agonist stimulation overrides FSS-induced Mac1 cleavage by promoting neutrophil 
adhesion under flow conditions, consistent with its role in the recruitment of 
neutrophils during the acute inflammatory response to infection or tissue damage. 
Figure 4.5. The involvement of cathepsin B in the fluid shear stress-induced detachment 
of neutrophils. 
(A-B) Representative images depicting shear-induced neutrophil detachment from platelet (A) 
or HUVEC (B) monolayers in response to 5 dyn/cm2 shear stress exposure over a 10 minute 
period. Neutrophils were treated with or without ctsB-specific inhibitor CA074-me (50 µM) 
and serine inhibitor aprotinin (AP; 5 µM). (C-D) The number of neutrophils remaining 
adherent to platelet (C) or HUVEC (D) monolayers after 10 minutes of shear exposure was 
normalized to the initial number of adherent neutrophils prior to shear exposure and plotted as 
mean ± SD, based on counts manually performed using ImageJ software. Neutrophils were 
left untreated or pretreated for 5 minutes with inflammatory agonist fMLP (1 µM), serine 
inhibitor aprotinin (AP; 5 µM), ctsB-specific inhibitor CA074-me (50 µM), or cysteine 
inhibitor E64 (30 µM).  n = 4 replicates in each group. *P < 0.05 compared to control; #P < 
0.05 compared to AP. Scale bars are 100 µm. 
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CHAPTER 5: DETERMINING THE EFFECTS OF EXTRACELLULAR 
CHOLESTEROL ELEVATIONS ON THE FLUID SHEAR STRESS CONTROL 
OF MAC1-DEPENDENT NEUTROPHIL ADHESION 
 Cholesterol is a structural component of lipid bilayers that modulates the membrane 
fluidity of a cell. As the cell membrane becomes enriched in cholesterol, the membrane 
becomes more rigid, decreasing its overall fluidity. This has implications for cell 
functionalities, such as actin polymerization, adhesion, and migration [125,126]. In the 
event that blood cholesterol rises to pathologic levels, such as during hypercholesterolemia, 
it is possible that the membranes of blood cells become enriched with cholesterol, which 
can impair their functions and contribute to microvascular dysfunction [127,128]. 
 Previously, our lab demonstrated that membrane cholesterol enrichment blocks the 
pseudopod retraction response of neutrophils to FSS, likely through an impact on the 
membrane fluidity of the cell [27]. Furthermore, we observed that cholesterol-related 
blockade of pseudopod retraction was linked to dysregulated tissue blood flow, observed 
as impaired tissue blood flow autoregulation in response to poRH [26]. This implicated 
impaired neutrophil FSS mechanosensitivity as an early forecaster of microvascular 
dysfunction. However, it was unclear how a deficit in neutrophil FSS sensitivity, indexed 
by the ability of fluid flow stimulation to restrict neutrophil activity, contributes to the 
progression of microvascular dysfunction involving changes in hemodynamic resistance.  
Reports in the literature [21], as well as the present dissertation thesis, indicate that 
the adhesivity of neutrophils appears to be minimized due to FSS regulation. This suggests 
that a deficit in neutrophil FSS sensitivity may contribute to dysregulated adhesion by 
impairing this mechanoregulatory control mechanism which involves ctsB-related Mac1 
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cleavage. Notably, dysregulated leukocyte adhesion in the microcirculation is also a feature 
of hypercholesterolemic pathobiology associated with microvascular dysfunction [77]. 
Combined, these support the possibility that an impaired FSS mechanosensitivity due to 
hypercholesterolemia manifests as dysregulation of not only neutrophil pseudopod activity, 
but also cell adhesion. 
The study described in this chapter focused on revealing new mechanistic insight 
regarding an impairment in the control of neutrophil adhesion by FSS as a putative link 
between the pathogenesis of hypercholesterolemia, dysregulated neutrophil adhesion in the 
microcirculation, and microvascular dysfunction. Specifically, we examined the possibility 
that excess cholesterol in the local environment of the neutrophils due to pathological blood 
cholesterol elevations attenuates their FSS-induced Mac1 cleavage response, which 
dysregulates neutrophil adhesion and leads to microvascular dysfunction. For this purpose, 
we conducted a series of ex vivo human blood studies to explore how cholesterol-related 
changes to the membrane fluidity of neutrophils could block FSS regulation of Mac1 
surface expression and neutrophil adhesion under flow. The present study also used a 
hypercholesterolemic murine animal model to confirm that pathological blood cholesterol 
elevations in the in vivo setting promotes dysregulation of neutrophil adhesion by FSS and 
that this dysregulation is potentially related to the onset of dysregulated tissue blood flow 
indicative of a deficit in the control of the microcirculatory function. 
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5.1 Methods 
5.1.1 Cells 
  Human subject recruitment, informed consent, and phlebotomy were approved by 
the University of Kentucky Institutional Review Board. Blood was harvested from 
asymptomatic volunteers into K2-EDTA-coated vacutainers (Becton-Dickinson) through 
the use of standard venipuncture, as previously reported. Human neutrophils were purified 
from the whole blood samples as described in section 3.1.1a and suspended in HBSS 
containing calcium and magnesium. Parallel to neutrophil isolation, platelets were also 
extracted from plasma as reported in section 4.1.1a. 
 
5.1.2 Human neutrophil experimental treatments 
  To enhance membrane cholesterol content, human neutrophils suspended in HBSS 
were treated with 0 – 10 µg/mL cholesterol:MβCD complexes for 15 minutes. After 
treatment, neutrophils were washed in PBS and resuspended in HBSS to remove excess 
cholesterol conjugates from the cell suspension. For some experiments, human neutrophils 
treated with 2 µg/mL cholesterol:MβCD conjugates were subsequently exposed to 0 – 7 
mM benzyl alcohol (BnOH) or 0 – 12 mM ethanol (EtOH) for 10 minutes to reverse the 
effects of cholesterol enrichment. 
 
5.1.3 Cone-and-plate shear exposure 
  Human neutrophils in HBSS were exposed to a constant (5 dyn/cm2) laminar FSS 
field for 10 min using a custom cone-plate device as described in section 3.1.2. 
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Experiments were also conducted with cell suspensions enriched with cholesterol:MβCD 
complexes and treated with or without BnOH or ethanol as described in section 5.1.2. 
Controls were parallel cell populations maintained under static (no-FSS), but otherwise 
similar experimental, conditions. 
 
5.1.4 Immunofluorescence 
  Immediately after cone-and-plate shear exposure, cells were fixed (1% p-
formaldehyde in phosphate buffer) and labeled with fluorescent antibodies in 1% BSA in 
PBS using standard immunocytochemistry described in section 3.1.3. For human 
neutrophils, FITC-conjugated mouse monoclonal antibody (mAb) to CD18 (clones 6.7) or 
Alexa Fluor 488-conjugated mouse mAb to CD11b (clone ICRF44) was used to assess 
surface expression of adhesion integrins. Rabbit polyclonal (pAb) against ctsB (clone Ab-
3) and Alexa Fluor 488-conjugated goat pAb (Invitrogen) were also used to assess total 
ctsB expression by permeabilized cells, respectively, as described in section 3.1.3. 
 
5.1.5 Neutrophil detachment assay 
  Autologous human platelets were deposited on sterile glass slides cleaned with 
NaOH and allowed to spread into a uniform coating for 30 min as described in section 
4.1.3. To create a flow channel for experimentation, the platelet-coated slides were 
interfaced with a polycarbonate base with both inlet and outlet ports, as described in section 
4.1.3. A pre-cut gasket separating the glass slide and the polycarbonate base formed a 200-
µm high parallel plate flow channel. 
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  For flow studies, neutrophils (5x106/mL) were pretreated for 15 minutes with 2 
µg/mL cholesterol:MβCD complexes. After PBS washing to remove excess complexes, 
neutrophils were treated for 10 minutes with or without 1 – 2 mM BnOH or 7 – 8 mM 
ethanol. Controls were neutrophils that were left untreated. Cells were then deposited on 
the platelet monolayers for 10 min, at which time non-adherent cells were rinsed away. A 
syringe pump was used to impose a FSS of 5 dyn/cm2 on the wall of the channel by 
perfusing HBSS through the chamber, as described in section 4.1.3. Bright field 
micrographs (100X magnification) of the neutrophils were acquired every 5 s over a 10 
min period, and neutrophil detachment was estimated by normalizing the number of 
neutrophils visible in each image against that present 30 seconds after flow initiation. This 
initial time point was defined to be t = 0 to ensure non-adherent cells were rinsed away 
prior to analyses. 
 
5.1.6 Animal studies 
5.1.6a Mice 
  All handling procedures were approved by the University of Kentucky Institutional 
Animal Care and Use Committees. Male low-density lipoprotein receptor-deficient 
(LDLR-/–) mice were purchased from the Jackson Laboratory and acclimated for 1 week 
prior to use. Starting from 8 weeks of age, mice were fed a high fat diet (HFD) enriched in 
saturated fat (21% wt/wt fat and 0.15% wt/wt cholesterol; Harland Teklad) for up to 8 
weeks to induce hypercholesterolemia. Controls were aged-matched LDLR-/- mice fed a 
normal diet (ND; regular chow) for the same duration. 
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5.1.6b Diffuse correlation spectroscopy 
  The blood flow recovery responses of mice were measured in real-time using Near-
Infrared (NIR) Diffuse Correlation Spectroscopy (DCS), a technique developed by our 
collaborator, Dr. Guoqiang Yu (University of Kentucky) [129,130]. DCS works by directly 
measuring the motion of RBCs to calculate the rate of blood flow. This technique utilizes 
a probe that contains a light source and a detector separated by 6 mm to enable detection 
of relative change of blood flow (rBF) within the muscle tissue [131]. The detector picks 
up the photons emitted from the light source and, depending on the degree of photon 
fluctuations, converts the signals into real-time rBF measurements. During blood flow, the 
RBCs are primarily responsible for the photon fluctuations that are detected. DCS has the 
advantage of being able to non-invasively measure rBF through deep tissue. The data on 
rBF for our experiments was displayed in real-time on a computer monitor to evaluate the 
responses of mice to blood flow occlusion (Fig. 5.1, A). 
  Prior to experimentation, mice were anesthetized by inhalation of 1% isoflurane 
(Butler Schein) and the hair on the right hindlimb of each mouse was shaved from the skin. 
A makeshift noose was fashioned from PVC tubing (0.05’’ outer diameter) and loosely 
wrapped around the proximal end of the right hindlimb so as to not restrict blood flow. 
Distal to the PVC noose, a foam pad equipped with a DCS probe was super-glued to the 
right hindlimb (Fig. 5.1, B). DCS measurement of rBF was recorded for 5 minutes to 
establish a baseline reading. Once the baseline was determined, the PVC noose was 
tightened until the real-time DCS measurement of rBF was reduced to zero. Data was 
collected for 5 minutes during occlusion, at which point the PVC noose was released using 
a high temperature surgical cautery pen to sever the knot and instantaneously reintroduce 
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flow to the target tissue of interest. Data continued to be collected until rBF had recovered 
to baseline levels. During the procedure, the body temperature of each mouse was 
maintained at 37°C for the duration of the experiment by using a heating pad. After rBF 
data had been collected, the mice were euthanized by thoracotomy and exsanguination. 
Blood was harvested from mice (~750 µL) for use in cone-and-plate shear experiments. A 
small aliquot of blood (~250 µL) was also set aside for cholesterol measurements. 
 
5.1.6c Analysis of DCS rBF measurements 
  MATLAB was used to analyze rBF data from LDLR-/- mice (Fig. 5.2). We plotted 
rBF against time in order to identify the highest rate of blood flow. This peak blood flow 
was defined to be the greatest rBF value attained after the end of occlusion. In order to 
reduce the variability due to noise, all rBF values within 10% of the peak blood flow were 
Figure 5.1. Animal study experimental set-up. 
(A) Figure depicting the experimental set-up used for murine analyses. The DCS 
instrumentation is shown to the right, and the heating pad with mouse is shown to the left. (B) 
Figure depicting the mouse on the heating pad. Tape was used to ensure the mouse remained 
stationary. The nose of the mouse was placed in a tube delivering 1% isoflurane, visible at the 
top of the image. The DCS probe is seen attached to the right hindlimb of the mouse.  
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averaged together and defined as adjusted peak flow (APF). We also calculated the length 
of time from cuff release to APF, which was reported as tAPF in our analyses. 
5.1.6d Plasma cholesterol quantification 
  Plasma was harvested from LDLR-/- mice blood aliquots by centrifugation (1000xg, 
5 min) and used to quantify the free, total, and esterified cholesterol levels in the mice. The 
concentration of free cholesterol was estimated by using the Free Cholesterol E kit (Wako) 
according to the manufacturer’s instructions. Absorbance values were measured at 600 nm 
using a BioTek microplate reader (µQuant). The concentration of total cholesterol was 
estimated by using the Infinity Cholesterol Reagent (Sigma Aldrich) according to the 
manufacturer’s instructions. Absorbance values were measured at 500 nm using the same 
BioTek microplate reader. The concentration of esterified cholesterol was estimated from 
the free and total cholesterol levels using the established relationship [132]: 
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝑜𝑜𝑜𝑜 = (𝑇𝑇𝑜𝑜𝐸𝐸𝑇𝑇𝑜𝑜 𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝑜𝑜𝑜𝑜 − 𝐹𝐹𝐸𝐸𝐸𝐸𝐸𝐸 𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝑜𝑜𝑜𝑜) × 1.67 
 
Figure 5.2. Representative image of adjusted peak flow analysis. 
This plot is used to identify all rBF values within 10% of the peak blood flow. The values are 
averaged together and defined as adjusted peak flow (APF). The length of time from cuff release 
to APF was also calculated and reported as tAPF in our analyses. 
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5.1.6e Cone-and-plate FSS exposure 
  Whole mice blood diluted 1:10 (v/v) with HBSS was exposed to a constant (5 
dyn/cm2) laminar FSS field for 10 min using a custom cone-plate device as described in 
section 3.1.2. Experiments were conducted with no additional treatments. Controls were 
parallel cell populations maintained under static (no-FSS), but otherwise similar 
experimental, conditions. 
 
5.1.6f Immunofluorescence 
  Immediately after cone-and-plate shear exposure, cells were fixed (1% p-
formaldehyde in phosphate buffer) and labeled with fluorescent antibodies in 1% BSA in 
PBS using standard immunocytochemistry described in section 3.1.3. For murine 
neutrophils, erythrocytes were removed after fixation using RBC lysis buffer (Sigma-
Aldrich) followed by PBS washes. Immunofluorescence was carried out using FITC-
conjugated rat mAb to CD18 (clone GAME-46), PE-conjugated rat mAb to CD11a (clone 
M17/4), or FITC-conjugated rat mAb to CD11b (clone M1/70) to assess surface expression 
of adhesion integrins, as described in section 3.1.3. 
 
5.1.7 Flow cytometry 
Flow cytometric analyses utilized an LSR II flow cytometer (Becton-Dickinson) 
interfaced with Becton-Dickinson FACsDiva software, as previously reported [59]. 
Neutrophil populations were identified through their FSC, SSC, and CD18 expression as 
previously described. The total fluorescence intensities representing the amount of bound 
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antibodies were used as measures of antigen specific expression level. By using the total 
fluorescence intensities, histograms of antigen-specific fluorescence intensities were 
generated for each sample using FCS Express 4 Flow Cytometry software (De Novo 
Software). Shear-induced changes in the antigen expression levels were normalized to 
those of their respective controls and expressed as “fold change”. 
 
5.1.8 Statistics 
  Quantitative data derived using human or murine neutrophils were expressed as 
mean ± SD for n ≥ 3 replicates. Statistical analyses were performed using JMP (SAS 
Institute). One-sample t-tests with P < 0.05 were used to identify significant fold changes 
or percent reductions in experimental treatments compared to a reference value. 
Comparisons between the means of experimental treatments were performed using 
ANOVA and post-hoc Tukey’s test with P < 0.05 indicating significant differences. Linear 
regression analysis was also performed using JMP to determine the correlation between 
cholesterol, FSS-induced Mac1 cleavage, APF, and tAPF. 
 
5.2 Results 
5.2.1 Membrane cholesterol enrichment blocks the shear-induced Mac1 cleavage response 
 Human neutrophils exposed to 5 dyn/cm2 FSS over a 10 min period exhibited reduced 
expression of CD18 and CD11b integrins relative to time-matched, unsheared controls 
(Fig. 5.3, A – B). This reduction in integrin expression was dose-dependently blocked for 
neutrophils pretreated with cholesterol. Notably, neutrophils treated with cholesterol 
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concentrations from 2 – 10 µM did not exhibit significant reductions in CD18 and CD11b 
integrins after being exposed to FSS (Fig. 5.3, C – D). These results suggested that 
membrane cholesterol enrichment impaired FSS-induced Mac1 cleavage response. 
5.2.2 Membrane fluidizers reverse cholesterol inhibition of Mac1 cleavage 
  Human neutrophils pretreated with 2 µg/mL cholesterol and exposed to 5 dyn/cm2 
FSS expressed similar levels of CD18 and CD11b on their surface relative to time-matched, 
unsheared controls (Fig. 5.4, A – B). BnOH, a membrane fluidizer [133], selectively 
recovered the ability of FSS exposure to promote a reduction in CD18 and CD11b surface 
Figure 5.3. Membrane cholesterol enrichment blocks FSS-induced Mac1 cleavage. 
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of intact 
CD18 (A) and CD11b (B) expressed on the surface of neutrophil suspensions maintained 
under no-flow conditions (blue line) or subjected to 5 dyn/cm2 shear stress (red line) using a 
cone-and-plate viscometer. A negative (IgG) staining control is also displayed in each plot 
(gray shading). Neutrophil suspensions were treated with 0 – 10 µg/mL cholesterol. (C-D) 
Based on florescent antibody binding, mean fluorescent intensities of sheared neutrophils 
were normalized to their respective no-flow controls and plotted as fold change ± SEM for 
CD18 (C) and CD11b (D) integrins. n = 3 replicates in each group. *P < 0.05 compared to a 
normalized control value of 1 (dotted line). #P < 0.05 compared to 5 µg/mL. ^P < 0.05 
compared to 10 µg/mL. %P < 0.05 compared to 2 µg/mL. 
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levels on neutrophils treated with 2 µg/mL cholesterol. Specifically, cholesterol-enriched 
neutrophils treated with 1 – 2 mM BnOH exhibited reduced CD18 and CD11b expression 
after FSS exposure, a response similar to that of naïve cells. In contrast, cholesterol-
enriched neutrophils treated with 0 – 0.5 mM and 5 – 7 mM BnOH did not exhibit 
reductions in CD18 and CD11b expression after FSS exposure (Fig. 5.4, C – D). These 
data provided evidence that the blockade of FSS-induced Mac1 cleavage depends on the 
membrane fluidity of the cells. Furthermore, there appears to be an optimal membrane 
fluidity that is conducive for an intact Mac1 cleavage response of neutrophils to FSS. 
Figure 5.4. Benzyl alcohol reverses the effects of membrane cholesterol enrichment. 
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of intact 
CD18 (A) and CD11b (B) expressed on the surface of cholesterol-enriched neutrophil 
suspensions maintained under no-flow conditions (blue line) or subjected to 5 dyn/cm2 shear 
stress (red line) using a cone-and-plate viscometer. A negative (IgG) staining control is also 
displayed in each plot (gray shading). Neutrophil suspensions were treated with 0 – 7 mM 
BnOH. (C-D) Based on florescent antibody binding, mean fluorescent intensities of sheared 
neutrophils were normalized to their respective no-flow controls and plotted as fold change ± 
SEM for CD18 (C) and CD11b (D) integrins. n = 3 replicates in each group. *P < 0.05 
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 1 mM. ^P < 
0.05 compared to 2 mM. %P < 0.05 compared to no chol. 
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  Similarly to BnOH, EtOH, another membrane fluidizing reagent [134], was shown 
to selectively reverse the blocking effects of membrane cholesterol enrichment on FSS-
induced Mac1 cleavage (Fig. 5.5, A – B). Briefly, treatment of cholesterol-enriched 
neutrophils with 7 – 8 mM EtOH resulted in reduced surface expression of intact CD18 
and CD11b integrin subunits on neutrophils after exposure to FSS, similar to that of naïve 
cells. In contrast, treatment of cholesterol-enriched neutrophils with 0 – 5 mM or 10 – 12 
mM EtOH did not exhibit reductions in CD18 and CD11b expression after FSS exposure 
(Fig. 5.5, C – D). These data further supported the existence of an optimal membrane 
fluidity level permissive for an intact Mac1 cleavage response of neutrophils to shear. 
Figure 5.5. Ethanol reverses the effects of membrane cholesterol enrichment. 
(A-B) Representative flow cytometry histograms depicting the fluorescent intensity of intact 
CD18 (A) and CD11b (B) expressed on the surface of cholesterol-enriched neutrophil 
suspensions maintained under no-flow conditions (blue line) or subjected to 5 dyn/cm2 shear 
stress (red line) using a cone-and-plate viscometer. A negative (IgG) staining control is also 
displayed in each plot (gray shading). Neutrophil suspensions were treated with 0 – 12 mM 
EtOH. (C-D) Based on florescent antibody binding, mean fluorescent intensities of sheared 
neutrophils were normalized to their respective no-flow controls and plotted as fold change ± 
SEM for CD18 (C) and CD11b (D) integrins. n = 3 replicates in each group. *P < 0.05 
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 7 mM. ^P < 
0.05 compared to 8 mM. %P < 0.05 compared to no chol. 
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5.2.3 Membrane cholesterol enrichment blocks the shear-induced release of cathepsin B 
  Human neutrophils exposed to 5 dyn/cm2 FSS over a 10 min period using a cone-
plate device exhibited reduced cytosolic levels of ctsB relative to time-matched, unsheared 
controls (Fig. 5.6, A). This observation suggested that FSS stimulated the release of ctsB 
into the extracellular milieu.  Pretreatment of neutrophils with cholesterol blocked this FSS 
response. Specifically, neutrophils treated with 2 – 10 µg/mL exogenous cholesterol and 
either exposed to FSS for 10 min or maintained under static no-flow conditions displayed 
similar levels of ctsB. Thus, exogenous cholesterol administration dose-dependently 
blocks FSS-induced ctsB release (Fig. 5.6, B). 
 
 
 
Figure 5.6. Cholesterol enrichment blocks shear-induced release of cathepsin B. 
(A) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB 
expressed in neutrophil suspensions maintained under no-flow conditions (blue line) or 
subjected to 5 dyn/cm2 shear stress (red line) using a cone-and-plate viscometer. A negative 
(IgG) staining control is also displayed in each plot (gray shading). Neutrophil suspensions 
were treated with 0 – 10 µg/mL cholesterol. (B) Based on florescent antibody binding, mean 
fluorescent intensities of sheared neutrophils were normalized to their respective no-flow 
controls and plotted as fold change ± SEM for ctsB. n = 3 replicates in each group. *P < 0.05 
compared to a normalized control value of 1 (dotted line). #P < 0.05 compared to 0 mM. 
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5.2.4 Membrane fluidizers reverse the cholesterol-related inhibition of cathepsin B release 
  Human neutrophils pretreated with 2 µg/mL cholesterol and exposed to 5 dyn/cm2 
FSS over a 10 min period exhibited similar expression levels of the protease ctsB relative 
to time-matched, unsheared controls (Fig. 5.7, A). BnOH selectively recovered the ability 
of FSS exposure to promote a reduction in ctsB expression by neutrophils treated with 2 
µg/mL cholesterol. Specifically, treatment of cholesterol-enriched neutrophils with 1 – 2 
mM BnOH reduced the expression of ctsB after FSS exposure, a response similar to naïve 
neutrophils. In contrast, cholesterol-enriched neutrophils treated with 0 – 0.5 mM and 5 – 
7 mM BnOH did not exhibit reduced ctsB expression after FSS exposure (Fig. 5.7, B). 
 
Figure 5.7. Benzyl alcohol recovers the shear-induced release of cathepsin B. 
(A) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB 
expressed in neutrophil suspensions treated with BnOH and maintained under no-flow 
conditions (blue line) or subjected to 5 dyn/cm2 shear stress (red line) using a cone-and-plate 
viscometer. A negative (IgG) staining control is also displayed in each plot (gray shading). 
Neutrophil suspensions were treated with 0 – 7 mM BnOH. (B) Based on florescent antibody 
binding, mean fluorescent intensities of sheared neutrophils treated with BnOH were 
normalized to their respective no-flow controls and plotted as fold change ± SEM for ctsB. n 
= 3 replicates in each group. *P < 0.05 compared to a normalized control value of 1 (dotted 
line). #P < 0.05 compared to no chol. ^P < 0.05 compared to 2 mM.  
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  Similarly to BnOH, EtOH was also able to selectively reverse the effects of 
membrane cholesterol enrichment (Fig. 5.8, A). Treatment of cholesterol-enriched 
neutrophils with 7 – 8 mM EtOH reduced the expression of ctsB after FSS exposure, a 
response similar to naïve neutrophils. In contrast, cholesterol-enriched neutrophils treated 
with 0 – 5 mM and 10 – 12 mM EtOH did not exhibit reductions in ctsB expression after 
FSS exposure (Fig. 5.8, B). Because we previously demonstrated ctsB to be involved in 
the selective cleavage of Mac1 integrins, these data further support the existence of an 
optimal membrane fluidity level permissive for an intact Mac1 cleavage response. Notably, 
the BnOH (1 – 2 mM) and EtOH (7 – 8 mM) concentrations which recover ctsB release 
also recover Mac1 cleavage, which is in line with the ability of ctsB to cleave Mac1 under 
shear exposure. 
 
Figure 5.8. Ethanol recovers the shear-induced release of cathepsin B. 
(A) Representative flow cytometry histograms depicting the fluorescent intensity of ctsB 
expressed in neutrophil suspensions treated with EtOH and maintained under no-flow 
conditions (blue line) or subjected to 5 dyn/cm2 shear stress (red line) using a cone-and-plate 
viscometer. A negative (IgG) staining control is also displayed in each plot (gray shading). 
Neutrophil suspensions were treated with 0 – 12 mM EtOH. (B) Based on florescent antibody 
binding, mean fluorescent intensities of sheared neutrophils treated with EtOH were 
normalized to their respective no-flow controls and plotted as fold change ± SEM for ctsB. n 
= 3 replicates in each group. *P < 0.05 compared to a normalized control value of 1 (dotted 
line). #P < 0.05 compared to 7 mM. ^P < 0.05 compared to 8 mM. %P < 0.05 compared to no 
chol.  
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5.2.5 Fluid shear stress-induced regulation of neutrophil adhesion is inhibited by 
membrane cholesterol enrichment 
  This experimental assay, similar to the one described in section 4.1.3, is used as a 
measure of neutrophil adhesivity. As previously shown, untreated human neutrophils pre-
adhered to platelet monolayers exhibited time-dependent cell detachment over a 10 min 
period of FSS exposure (Fig. 5.9, A). Pretreatment of neutrophils with 2 µg/mL cholesterol 
prior to incorporation into our cell detachment assay attenuated the ability of FSS exposure 
to promote their detachment from platelet monolayers (Fig. 5.9, B). This blockade was 
reversible by treating cells with membrane fluidizers, BnOH or EtOH, at concentrations 
that we showed to be capable of recovering FSS-induced Mac1 cleavage and ctsB release 
by neutrophils treated with similar concentrations of exogenous cholesterol. Specifically, 
neutrophils pretreated with 2 µg/mL cholesterol and subsequently subjected to the flow-
based cell detachment assay in the presence of either 2 mM BnOH or 8 mM EtOH exhibited 
significant detachment from platelet layers under FSS exposure, a response that was similar 
to that of untreated cells. 
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Figure 5.9. Fluid shear stress-mediated regulation of neutrophil adhesion is inhibited by 
cholesterol enrichment. 
(A) Representative images depicting shear-induced neutrophil detachment from platelet 
monolayers in response to 5 dyn/cm2 shear stress exposure over a 10 minute period. 
Neutrophils were left untreated or pretreated with or without 2 µg/mL cholesterol, 2 mM 
BnOH, or 8 mM EtOH. (B) The number of neutrophils remaining adherent to platelet 
monolayers after 10 minutes of shear exposure was normalized to the initial number of 
adherent neutrophils prior to shear exposure and plotted as mean ± SEM, based on counts 
manually performed using ImageJ software. Neutrophils were left untreated or pretreated with 
or without 2 µg/mL cholesterol, 2 mM BnOH, or 8 mM EtOH.  n = 3 replicates in each group. 
*P < 0.05 compared to 2 µg/mL cholesterol. Scale bars are 100 µm. 
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5.2.6 Hypercholesterolemia inhibits fluid shear stress-induced Mac1 cleavage  
   Table 5.1 lists the free, total, and esterified cholesterol concentrations in the blood 
of male LDLR-/- mice fed a ND or HFD for 6 – 8 weeks. We observed increases in 
cholesterol levels that were dependent on the diet duration, consistent with the gradual 
onset of hypercholesterolemia due to high fat intake. The free and total cholesterol levels 
of 8 week HFD mice were significantly elevated compared to 6 week HFD mice. In 
addition, the cholesterol levels of LDLR-/- mice fed a HFD were significantly elevated 
compared to LDLR-/- mice fed a ND, further confirming the onset of hypercholesterolemia 
in HFD mice. The free and total cholesterol levels of 6 week ND mice, in contrast, were 
no different than those of 8 week ND mice. 
Cholesterol 
Type Diet 
Cholesterol Concentration (mg/dl) 
6 weeks 8 weeks 
Free 
ND 75.8 ± 8.1 69.8 ± 16.5 
HFD 304.0 ± 86.1 * 416.6 ± 60.3 *# 
Total 
ND 225 ± 27.8 211.8 ± 44.8 
HFD 759.2 ± 78.3 * 829.0 ± 31.8 *# 
Esterified 
ND 249.2 ± 33.6 237.1 ± 49.6 
HFD 760.1 ± 98.5 * 688.6 ± 70.5 *# 
 Murine leukocytes in blood harvested from LDLR-/- mice fed a ND and exposed to 5 
dyn/cm2 FSS for 10 min with a cone-plate device exhibited reduced surface expression of 
CD18 and CD11b, but not CD11a, integrins relative to time-matched, unsheared controls 
(Fig. 5.10, A – B). In contrast, FSS exposure had little effect on the surface expression of 
intact CD18, CD11a, and CD11b integrins on leukocytes in the blood of mice fed a HFD 
for either 6 weeks or 8 weeks. Leukocytes from the 6 week HFD mice exhibited an 
 
Table 5.1. Cholesterol concentrations in the blood of LDLR-/- mice. 
*P < 0.05 compared to diet duration-matched LDLR-/- mice fed a normal diet (ND) 
#P < 0.05 compared to LDLR-/- mice fed a high fat diet (HFD) for 6 weeks 
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attenuated FSS-induced Mac1 cleavage response, while leukocytes from the 8 week HFD 
mice exhibited a complete inhibition of FSS-induced Mac1 cleavage. 
  Linear regression analyses indicated that, independent of diet type and duration, 
plasma cholesterol concentrations of LDLR-/- mice were positively correlated with the 
FSS-related surface expression of CD18 and CD11b, but not CD11a, integrins on 
neutrophils (Fig. 5.11, A – B). As cholesterol (free and total) concentrations increased, 
the integrin surface expression (CD18 and CD11b) was elevated on neutrophils exposed 
to FSS. This data provided confirmation that FSS-induced Mac1 cleavage is affected by 
pathologic cholesterol elevations, related to hypercholesterolemia. 
 
 
 
Figure 5.10. Hypercholesterolemia inhibits the fluid shear stress-induced Mac1 cleavage 
response. 
(A-B) Based on florescent antibody binding to neutrophils from mice fed a diet for 6 weeks 
(A) or 8 weeks (B), mean fluorescent intensities of sheared neutrophils were normalized to 
their respective no-flow controls and plotted as fold change ± SEM for CD18, CD11a, and 
CD11b integrins. n = 8 replicates in each group. *P < 0.05 indicates significant differences 
between normal diet (ND) and high fat diet (HFD) mice. #P < 0.05 compared to a normalized 
control value of 1 (dotted line). 
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Figure 5.11. Plasma cholesterol concentration is positively correlated with Mac1 
expression under fluid shear stress exposure. 
(A-B) The free (A) and total (B) cholesterol concentrations of LDLR-/- mice were plotted 
against the surface expression of CD18, CD11a, and CD11b integrins after exposure to FSS. 
*P < 0.05 indicates significant correlation between cholesterol concentration and integrin 
expression. 
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5.2.7 Cholesterol-related impairment of fluid shear stress-induced Mac1 cleavage is 
negatively correlated with APF 
  We used poRH as a measure of evaluating tissue blood flow autoregulation and 
microvascular function in hypercholesterolemic animals. The rBF curves plotted in 
MATLAB (Fig. 5.12, A-B) for LDLR-/- mice fed a ND or HFD were similar in response 
to that of reactive hyperemia reported in humans [129,131]. To evaluate the tissue blood 
flow response in our mice, we analyzed the peak blood flow attained immediately after 
cuff occlusion had ended. All rBF data within 10% of the peak blood flow was averaged 
and reported as APF to reduce noise. Additionally, the duration of time from cuff release 
to APF was measured and reported as tAPF. 
 
 
 
 
 
 
 
      
 
 
 
Figure 5.12. Representative images of rBF from normal diet and high fat diet mice. 
(A-B) The ND (A) and HFD (B) rBF curves of LDLR-/- were plotted in MATLAB against 
time. By using the adjusted peak flow (APF) and length of time to APF (tAPF), we could 
evaluate the reactive hyperemia of these mice. 
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  On average, the APF of LDLR-/- mice fed a HFD for both the 6 week and 8 week 
durations appeared to be reduced in comparison to LDLR-/- mice fed a ND (Fig. 5.13, A). 
However, these diet related changes were not associated with significant difference 
between ND and HFD mice. Likewise, the tAPF of LDLR-/- mice fed a ND, on average, 
appeared to be prolonged in comparison to LDLR-/- mice fed a HFD (Fig. 5.13, B) 
suggesting that tissue blood flow autoregulation in hypercholesterolemic mice may have 
also been impaired. However, we did not observe a significant difference between ND 
and HFD mice after 6 and 8 weeks of diet.  
 
 
 
 
 
 
 
   
  To determine if there was a link between blood cholesterol levels and the tissue 
blood flow parameters used in the present study, we performed correlation analyses on 
APF and tAPF independent of diet type or diet duration. Table 5.2 summarizes the results 
of correlation analyses between plasma cholesterol concentration, FSS-related surface 
integrin expression, and APF or tAPF. APF was negatively correlated with free and total 
cholesterol concentrations, indicating that as plasma free or total cholesterol levels in the 
Figure 5.13. The poRH response appears to be disrupted in hypercholesterolemic mice. 
(A-B) The poRH response of LDLR-/- mice fed a ND or HFD was evaluated and reported as 
APF (A) and tAPF (B). Bars represent average ± SEM for APF and tAPF. n = 4 replicates in 
each group. No significant differences were observed between ND and HFD. 
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blood rose, there was an increase in the degree to which APF was attenuated, which is 
indicative of an impaired tissue blood flow autoregulation response to poRH. 
  Additionally, APF was negatively correlated with FSS-related expression of 
CD18 and CD11b integrins. This indicated that a high expression of Mac1 integrins on 
neutrophils, likely due to an impaired FSS mechanotransduction response, may contribute 
to an impaired autoregulation response to poRH in mice. We also observed that tAPF was 
positively correlated with cholesterol concentrations (free and total), indicating that mice 
with high plasma cholesterol were likely to have a slow poRH response. However, there 
was no apparent correlation detected between tAPF and the FSS-related integrin 
expression of Mac1 or LFA1. 
  FSS-Related Integrin Expression Cholesterol Concentration 
  CD18 CD11a CD11b Free Total 
APF -0.610* -0.201 -0.569* -0.455* -0.572* 
tAPF 0.174 -0.188 0.291 0.472# 0.501# 
 
5.2.8 Summary of data findings/interpretations 
The results of the present study provided first evidence for the following significant 
findings. 
• There exists an optimal membrane fluidity permissive of FSS-induced Mac1 cleavage 
(both ctsB release and Mac1 cleavage) 
Table 5.2. Correlation analysis of APF. 
*P < 0.05 indicates significant correlation with APF 
#P < 0.05 indicates significant correlation with tAPF 
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• Extracellular cholesterol elevations block the FSS control of Mac1 surface levels and 
neutrophil adhesion, likely through effects on membrane fluidity 
• Diet-induced hypercholesterolemia is associated with impairment of FSS-induced 
Mac1 cleavage by neutrophils. 
• FSS-induced Mac1 cleavage and plasma free and total cholesterol concentrations are 
correlated with disrupted tissue blood flow in LDLR-/- mice, suggesting a link 
between cholesterol-related impairment of neutrophil activity and microvascular 
dysfunction associated with hypercholesterolemia.   
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CHAPTER 6: DISCUSSION 
6.1 First Insight into a Putative Role for Fluid Shear Stress-Induced Cathepsin B 
Release in the Regulation of Mac1 Surface Expression 
6.1.1 Human neutrophil Mac1 expression is regulated by fluid shear stress-induced release 
of cathepsin B 
When exposed to FSS, neutrophils release ctsB, a cysteine protease, to cleave CD18 
integrins [23]. Researchers identified the role of ctsB in FSS mechanotransduction through 
the use of protease inhibitors. There are six main classifications of proteases: cysteine, 
serine, aspartic, glutamic, threonine, and metalloprotease [135]. Each protease family can 
be selectively blocked through the use of different inhibitors that are commercially 
available. Using a panel of protease inhibitors, researchers observed that only a broad-
spectrum cysteine protease inhibitor, E64, could block shear-induced CD18 cleavage. The 
cysteine protease ctsB was later identified after CA074Me, a membrane-permeable 
inhibitor specific for ctsB [136], was also demonstrated to prevent FSS-induced CD18 
cleavage [23]. Later experiments would later implicate the FSS-induced release of ctsB 
into the extracellular environment through the use of the non-permeable ctsB inhibitor, 
such as CA074 [93]. 
While the protease involved in CD18 cleavage had been identified, it was unknown 
which of the four different CD18 heterodimers, potentially expressed on the neutrophil 
surface, was targeted for cleavage. Among the four CD18 integrin subtypes, CD11a/CD18 
(or LFA1) and CD11b/CD18 (or Mac1) are expressed in high quantities on neutrophils, 
while very little expression of CD11c/CD18 and CD11d/CD18 is reported [137-139]. This, 
combined with the important role of LFA1 and Mac1 in neutrophil adhesion and migration 
[115,140], made it likely that ctsB targeted either CD11a or CD11b, if not both integrins. 
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Previous research in our lab identified that neutrophils selectively cleaved Mac1 integrins 
on human neutrophils, leaving LFA1 integrins untargeted [59]. This narrowed our focus to 
the CD18 and CD11b subtypes. But, because the aforementioned research used the broad-
spectrum cysteine protease inhibitor, E64, to determine that Mac1 was selectively cleaved 
due to FSS, it was still unclear if ctsB was capable of cleaving CD11b in addition to CD18. 
In the present study, it is apparent that ctsB is involved in the selective cleavage of 
Mac1 integrins since it can cleave both CD18 and CD11b integrin subunits. CD11a, in 
contrast, is not cleaved due to FSS-induced ctsB release. It is interesting to point out that 
FSS exposure reduces CD18 expression by 20 – 30%, and decreases intact CD11b surface 
levels by up to 50% [59]. This type of proportional relationship would only be possible if 
neutrophils express similar levels of LFA1 and Mac1, a claim supported by prior analyses 
of total CD18 subtype expression on neutrophils [141]. Furthermore, these proportional 
values suggest that during proteolysis of Mac1, CD18 cleavage occurs after CD11b 
proteolysis. Since FSS exposure does not downregulate LFA1 expression, it is likely that 
CD11a is somehow able to prevent the cleavage of its partner CD18 subunit. Thus, FSS 
exposure does not promote cleavage of all the CD18 integrins off the cell surface, only the 
Mac1-associated ones. It is also possible that CD11a blocks the access of ctsB to CD18, 
thereby enabling LFA1 to remain on the neutrophil surface in the presence of FSS.  
At this point, the reason for why Mac1, but not LFA1 is cleaved under FSS is 
unknown. One possible explanation may be explained by the specific contributions of 
LFA1 and Mac1 in recruiting neutrophils to the microvasculature during acute 
inflammation. LFA1 is typically involved in the early rolling and loose capture stages of 
neutrophil recruitment to the microvascular wall [58].  In the absence of inflammatory 
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agonist stimulation, LFA1 may remain intact under FSS exposure to enable the neutrophils 
to still interact with the microvascular endothelium as part of their immune surveillance 
functionality. Since LFA1 forms loose interactions with the microvasculature [58], this 
would enable neutrophils to reversibly bind to the vessel wall under FSS exposure but still 
not commit down the inflammatory cascade if they are not needed. In contrast, Mac1 may 
be cleaved as a key checkpoint to prevent the commitment of neutrophils along the 
inflammatory cascade. Since Mac1 supports the firm adherence of neutrophils to the 
microvasculature [58], cleavage of this integrin would prevent neutrophil adherence to, 
arrest on, and migration along, the vessel wall and, in turn, maintain neutrophils freely-
floating in the bloodstream. Considering that neutrophil binding to the microvasculature 
may influence endothelial-mediated vasomotor activity and/or affect the cross-sectional 
area to flow, FSS-induced ctsB release and Mac1 cleavage may preserve microvascular 
blood flow regulation and reduce apparent viscosity [72,142], thereby minimizing 
microvascular flow resistance. 
 In addition to analyzing Mac1 cleavage, we also focused on the release of ctsB 
under shear exposure. The time-dependent release of ctsB in this study agrees with that 
reported for CD18 and CD11b cleavage in previous studies [59]. Furthermore, the observed 
extracellular release of ctsB in a soluble form is also supported by our prior experiments 
[93]. While the possibility that a lysosomal protease, such as ctsB, is capable of cleaving 
Mac1 in the extracellular domain is inconsistent with the widespread view that lysosomal 
proteases typically function optimally in an acidic pH [143] and not a neutral pH outside 
the cell, evidence supports the extracellular actions of ctsB for many cells. For example, 
tumor cells and lymphocytes both secrete ctsB, which has been demonstrated to remain 
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stable and functional at neutral pH for extended periods of time [144-147]. Therefore, it is 
plausible that ctsB remains functional and able to cleave Mac1 integrins upon its release 
by neutrophils. 
Interestingly, FSS exposure has been shown to increase granular motion in the 
neutrophil cytosol, which may increase the likelihood of degranulation [21]. This increased 
granular motion may be linked to the ability of FSS to induce actin depolymerization [55], 
considering granule exocytosis is dependent on actin remodeling [148,149]. Thus, the FSS-
induced increase in granular motion may represent a key aspect of the mechanism that 
underlies the ability of FSS to promote ctsB release. It should be emphasized that the FSS-
induced degranulation of neutrophils is unlikely to be due to mechanical trauma which 
other investigators reported for neutrophils under flow conditions [150]. The FSS levels 
used in the present study were well below those used in these earlier studies [150]. Future 
studies will be required to link FSS-induced degranulation with the release of ctsB at low 
shear magnitudes.  
 
6.1.2 The shear-induced CD18 cleavage response is characteristic of neutrophils 
In addition to confirming the selective cleavage of Mac1 by FSS-induced ctsB 
release, we also determined whether the ability to regulate Mac1 expression by FSS 
exposure was characteristic of neutrophils. We selected HL60 promyelocytes for use in our 
experiments. HL60 cells are capable of differentiating into cells that express a variety of 
different phenotypes, including neutrophilic [109]. DHL60-NCs approximate human 
neutrophils after undergoing morphological changes and upregulating their expression of 
FPR [151] and CD18 integrins on their surface [92,109]. In fact, dHL60-NCs have been 
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validated as a model for various neutrophil functions, including migration and chemotaxis 
[107,109,152]. Furthermore, dHL60-NCs can be utilized in transfection experiments and 
are sustainable in culture for up to one week. This is in contrast to human neutrophils, 
which are much more difficult to transfect due to their short (i.e., < 24 hour) lifespan once 
outside the body [153,154]. 
 The results from our experiments involving dHL60-NCs confirmed that the FSS-
induced cleavage of CD18 integrins is phenotypic of neutrophils. The total reduction in 
CD18 expression on the dHL60-NC surface is similar to that observed for human 
neutrophils exposed to shear [59]. Additionally, FSS-induced CD18 cleavage of dHL60-
NCs occurs at an extracellular domain on the integrin, much like with human neutrophils. 
This was verified due to the similar expression of intracellular CD18 between sheared and 
unsheared samples. We also used E64, a protease inhibitor incapable of crossing the cell 
membrane [155-157], to confirm that cysteine proteases are released into the extracellular 
milieu and cleave CD18 integrins, in line with our human data. 
Notably, the specific integrin cleaved under FSS exposure was found to differ 
between human neutrophils and dHL60-NCs. While human neutrophils cleave Mac1, we 
observed dHL60-NCs to cleave LFA1. Moreover, E64 prevented shear-induced CD18 
cleavage, but only partially blocked cleavage of CD11a subunits. This raised the issue of 
how shear-induced CD18, but not CD11a, cleavage was blocked in the presence of E64. 
We ruled out the possibility that our flow cytometric analyses were detecting the cleavage 
of CD18 dimerized to CD11c, as dHL60-NCs had no detectable expression of this subunit. 
Instead, it may be possible that different proteases are responsible for cleavage of CD18 
and CD11a by dHL60-NCs. Furthermore, since ctsB expression by dHL60-NCs was much 
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lower in comparison to primary neutrophils [158], it is possible that dHL60-NCs express 
other cysteine proteases capable of cleaving CD18 and CD11a, but not CD11b, integrin 
subunits under shear exposure. The variance in granule distribution between human 
neutrophils and HL60s may account for the difference in protease expression for these two 
cell types [159]. Alternatively, these cell types may also degranulate differently when 
exposed to shear. 
While we did not identify the protease involved in FSS-induced CD11a cleavage 
for dHL60-NCs, we excluded the involvement of cysteine, serine, and aspartyl proteases. 
Since we previously observed lymphocytes to exhibit FSS-induced cleavage of CD11a 
[59], a common mechanism or protease may link the FSS cleavage responses of 
lymphocytes and dHL60-NCs. We also focused on the involvement of MMPs, as MMP-9 
was previously implicated in cleavage of CD18 [160]. However, doxycycline, an antibiotic 
with broad proteolytic activity against MMP-9 and cysteine proteases, blocked cleavage to 
the same degree as E64, suggesting that MMP-9 is not involved. However, additional 
studies are needed to fully rule out this possibility. 
Despite the difference in integrin cleavage between human neutrophils and dHL60-
NCs, these two cells share a similar FSS mechanotransduction response, i.e., CD18 
cleavage. Importantly, we demonstrated that shear-induced CD18 cleavage may be blocked 
in the presence of threshold concentrations of fMLP. Cleavage of the corresponding CD11 
subunit, either CD11b for human neutrophils or CD11a for dHL60-NCs, was also affected 
by the same threshold concentrations of fMLP. Notably, the threshold (> 1 μM) of fMLP 
required to block integrin cleavage was the same as that reported for attenuating the FSS-
induced pseudopod retraction response [20].  
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Ultimately, our results pointed toward FSS-induced cleavage of CD18 as a 
characteristic trait of neutrophil-like cells. We verified that human neutrophils cleave Mac1 
through extracellular release of ctsB in response to FSS stimulation. Furthermore, dHL60-
NCs cleave CD18 integrins in response to FSS exposure, but were found to express very 
little ctsB and, instead, cleave CD11a. Despite this discrepancy in the CD18 integrin 
cleavage response to FSS, the dHL60-NCs would be a useful transfectable culture model 
to study neutrophil FSS mechanotransduction responses. By transfecting dHL60-NCs to 
express ctsB, for example, it may be possible to study FSS-induced Mac1 cleavage in these 
cells as a model for human neutrophils.  
Overall, the observations from the studies discussed in this section suggest that 
CD18 cleavage acts in conjunction with pseudopod retraction under non-inflamed 
conditions to minimize neutrophil activation when they are not needed. This provided the 
foundation for future experiments involving the regulation of neutrophil adhesion and 
migration through FSS-induced ctsB release. 
 
6.2 A Role for Fluid Shear Stress-Induced Cathepsin B Release in the Restriction of 
Neutrophil Adhesive Functions 
6.2.1 The influence of cathepsin B on neutrophil-substrate interactions during migration 
under no-flow conditions 
 Originally, it was anticipated that exogenous ctsB would impair the ability of 
neutrophils to migrate by reducing their adhesive interactions with substrates. Rather than 
reducing the migration velocity of cells, exogenous ctsB actually enhanced neutrophil 
motility under no-flow conditions. This observation was in agreement with previous 
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studies [93]. Although this seems counter-intuitive, it is conceivable that ctsB enhances 
neutrophil motility by altering Mac1-dependent processes involved in the pseudopod 
projection/retraction dynamics during neutrophil migration. 
 In essence, neutrophil migration depends on cyclical pseudopod projection and 
retraction to induce movement in a specific direction [161,162]. The rapid F-actin 
polymerization and formation of cytoskeletal networks at the “leading edge” of a 
neutrophil enables lamellipodia to extend from the cell. Once projected, the lamellipodia 
are filled with cytoplasm to become functioning pseudopods. The presence of adhesive 
integrins, including Mac1, on the functioning pseudopods enables the neutrophil to adhere 
to biological substrates and pull itself forward. As the cell body moves forward, the F-actin 
begins to rapidly depolymerize not long after pseudopod formation, breaking down the 
cytoskeletal networks that provide structure to the adherent pseudopod [163]. This, in turn, 
causes the eventual retraction of this pseudopod (referred to as the uropod) at the “trailing 
edge” of the neutrophil as the cell body continues to advance forward. Ultimately, 
neutrophil migration rate is dictated by this cyclical formation of lamellipodia and 
subsequent retraction of uropodia. 
In regard to our migration experiments, performed under no-flow conditions, it may 
be that the addition of exogenous ctsB to migrating neutrophils had an additive effect on 
their motile function by cleaving the extracellular domains of Mac1. This, in turn, would 
help to detach uropods and, ultimately, accelerate neutrophil migration. Under flow 
conditions, it may be possible that exogenous ctsB (i.e., due to FSS-induced ctsB release) 
cooperates with other cell motility processes, such as calpain-mediated cleavage of 
intracellular CD18 integrins [164] and Mac1 unbinding kinetics to substrate-bound ligands 
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[23,26]. This would be in line with the observed increase in pseudopod retraction rates that 
occurred in the presence of exogenous ctsB under no-flow conditions. Moreover, inhibiting 
ctsB activity did not have a significant effect on baseline pseudopod retraction and 
extension rates, further supporting an additive effect of Mac1 cleavage on cell motility. 
 While we observed large increases in pseudopod retraction rates, we also observed 
small increases in pseudopod extension rates. It is likely that small increases in pseudopod 
extension rates for ctsB-stimulated neutrophils were a secondary effect of the large 
increases in retraction rates. CtsB-enhanced pseudopod retraction, which involves 
accelerated actin depolymerization, likely promoted an increase in the amount of G-actin 
monomers in the cytosol. Such an increase in G-actin availability would facilitate the 
formation of cytoskeletal structures to support new pseudopod projection. However, this 
scenario is speculative and remains to be confirmed. 
 It is interesting to note that, while ctsB enhanced pseudopod disengagement 
through Mac1 cleavage, FSS appears necessary to prevent the formation of new 
pseudopods on neutrophils. While we observed ctsB to enhance pseudopod retraction, the 
cells still were able to form new pseudopods. However, under flow conditions, only 
pseudopod retraction is observed during FSS-induced ctsB release; the cells don’t form 
new pseudopods. This may be due to the contributions of FPR, which is reported to be a 
neutrophil mechanosensor involved in regulating Rac1 signaling associated with actin 
dynamics [108].  
Briefly, Rac1, a small guanine triphosphase (GTPase) belonging to the Ras protein 
superfamily [165], initiates cytoskeletal reorganization, actin polymerization, and 
membrane protrusion when activated [166]. Under FSS exposure in neutrophils, Rac1 
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activity is significantly decreased, in line with a reduction in pseudopod formation [108]. 
Notably, FPR expression is necessary for neutrophils to form new pseudopod projections 
[92]. When neutrophils are exposed to FSS, the expression of FPR on the membrane 
surface is downregulated through receptor internalization [63]. Since constitutive FPR 
expression is necessary for pseudopod formation, FPR internalization likely prevents the 
formation of new pseudopods, potentially by reducing Rac1 activity. This suggests that 
FSS-induced ctsB release and FSS-induced FPR internalization work in conjunction to 
retract pseudopods and prevent their formation under flow conditions.  
Finally, although dHL60-NCs naturally express a low level of ctsB, we were able 
to overexpress this protease through transfection and show that both pseudopod activity 
and neutrophil motility were slightly elevated in the transfected dHL60-NCs in a similar 
fashion to primary neutrophils. These observations supported the ability of ctsB to 
influence neutrophil pseudopod activity. Overall, the observations from the present study 
provided first evidence that release of ctsB is another way by which neutrophils may 
modulate their migration rates in line with its ability to cleave surface Mac1 integrins.  
 
6.2.2 Fluid shear stress-induced cathepsin B release can restrict neutrophil adhesion 
through Mac1 cleavage 
 In addition to its effects on neutrophil motility, we also anticipated that ctsB was 
involved in directly regulating neutrophil binding/adhesion to biological substrates. Under 
physiologic conditions, many mechanisms are in place to ensure neutrophils remain freely-
floating in the circulation. Some of these regulatory mechanisms are tied to endothelial cell 
functions. For example, FSS exposure in the physiologic range can induce endothelial cells 
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to release NO, an anti-inflammatory signaling molecule which can minimize leukocyte 
adhesion to the endothelium [167]. When exposed to FSS, endothelial cells also 
downregulate the expression of adhesion molecules that act as receptors for Mac1, further 
diminishing the ability of leukocytes to adhere under physiologic conditions [167,168]. 
 Much like the endothelial cells, neutrophils appear to also be capable of regulating 
their own adhesive capabilities. Shedding of Mac1, for example, allows neutrophils in 
interstitial tissues to detach from extracellular matrix during chemotaxis [169]. Our own 
lab took this a step further by investigating the involvement of ctsB in neutrophil adhesion 
to other cells, based on its interactions with Mac1. Previously, the FSS-induced release of 
ctsB was reported to reduce the binding of neutrophils in suspension to platelets and 
fibrinogen, a Mac1 ligand [59]. This implicated FSS-induced ctsB release and Mac1 
cleavage as a preventative measure against neutrophil adhesion to other cells in the blood. 
Moreover, these findings suggested that ctsB, in addition to regulating the adhesion of 
neutrophils in suspension, could also regulate neutrophil adhesion to unstimulated 
endothelium in the microvasculature, which expresses Mac1 counter-receptors. 
 The idea for the ex vivo, flow-based detachment assay used in the present study 
came from experiments performed by Moazzam et al [21]. Using intravital microscopy, 
they found that leukocytes would sediment to, adhere to, and migrate along the 
microvascular endothelium during transient periods of blood stasis imposed by upstream 
microvessel occlusion. But when flow was reconstituted, they would detach in a time-
dependent fashion and be carried away in the circulation. It should be emphasized that the 
detachment resembled a mechanobiologically-driven process and not a result of a physical 
shearing off of the cells.  
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For our studies, we mimicked this scenario using a microfluidics approach. We 
studied the ability of FSS exposure to promote the detachment of neutrophils from platelet 
monolayers as a way to quantify the ability of mechanical stimulus to restrict adhesion. 
Neutrophils bind to platelets primarily through Mac1 integrins, which allowed us to focus 
on the role of FSS-induced ctsB release [113]. We also conducted similar studies using 
HUVECs as a model endothelial cell line. The use of an unstimulated venous endothelial 
cell line allowed us to more closely approximate the in vivo conditions in the 
microvasculature. 
Whether adhered to platelets or unstimulated endothelium, the outcomes of our ex 
vivo/in vitro flow-based analyses confirmed that FSS regulated the adhesive capacity of 
neutrophils by promoting their detachment from platelets and from endothelial 
monolayers. Based on our observations, FSS-induced release of ctsB likely served to sever 
Mac1-dependent neutrophil adhesion. Importantly, FSS was only found to regulate 
neutrophil adhesion in the absence of agonist stimulation. When stimulated with fMLP 
concentrations above threshold levels that block FSS-induced pseudopod retraction or 
CD18 cleavage, the neutrophils remained adherent to substrates even under fluid flow 
stimulation. This outcome is consistent with the likelihood that an acute inflammatory 
scenario overrides the FSS mechanotransduction response in order to recruit neutrophils 
only when they are needed. Taken together, these observations provided evidence that FSS-
induced ctsB is a control mechanism that restricts Mac1 dependent adhesion of neutrophils 
under physiological (i.e., non-inflamed) conditions. 
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6.3 The Importance of an Optimal Membrane Fluidity in a Functioning Fluid Shear 
Stress Mechanotransduction Response 
6.3.1 An optimal membrane fluidity is permissive of shear-induced Mac1 cleavage 
A growing body of evidence, including that presented in this dissertation, indicates 
that FSS mechanotransduction regulates neutrophil activity under physiologic conditions 
to keep them quiescent and suspended within the circulation. While inflammatory agonist 
stimulation is one way the circulation may supersede the neutrophil mechanosensitivity, it 
is also possible for neutrophils to become unresponsive to FSS under pathological 
conditions. It is this dysregulation that we believe may contribute to chronic activation, 
even in the presence of flow. SHRs, for example, are associated with neutrophils that do 
not retract pseudopods when exposed to shear stress [25]. This is thought to involve the 
dependence of blood pressure in SHRs on plasma levels of glucocorticoids and the 
expression of glucocorticoid receptors on the neutrophil membrane [170,171]. 
Glucocorticoids have been shown to block FSS-induced pseudopod retraction [24]. 
However, soluble signaling molecules are not the only way to impair cell 
mechanosensitivity, as changes to the cell membrane itself have also been observed to do 
this [26,27].  
Impaired FSS mechanotransduction responses have previously been demonstrated 
in our lab for neutrophils in hypercholesterolemic blood [27]. When exposed to shear in a 
cone-and-plate viscometer, neutrophils from hypercholesterolemic mice are unresponsive 
to FSS with a deficient pseudopod retraction response to FSS. We reported this to be 
dependent on the cholesterol-related membrane fluidity of the cell. 
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 Additionally, we found that the degree of impairment in neutrophil 
mechanosensitivity occurred in a time-dependent fashion (as early as 2 weeks after diet 
initiation) that tracked with the gradual increases in blood cholesterol levels over the 
duration of high fat dieting intended to induce hypercholesterolemia in mice [27]. It is 
likely that, as blood cholesterol concentrations increased over the HFD duration, there was 
an increased accumulation of cholesterol in the neutrophil membrane. In support of this, 
hypercholesterolemia reportedly increases the cholesterol concentration of blood cell 
membranes [104,172]. Conceivably, this gradually increased the degree of impairment in 
neutrophil mechanosensitivity during the progression of hypercholesterolemia, something 
previously reported by our laboratory [27] and observed in the present study. 
The cholesterol-related impairment of neutrophil FSS mechanosensitivity may also 
be linked to microvascular dysfunction. Another study performed in our lab found that 
neutrophils in hypercholesterolemic mice contributed to the dysregulation of tissue blood 
flow autoregulation in response to poRH, a measure of microvascular function [26]. This 
suggested that cholesterol-enriched neutrophils with impaired FSS mechanosensitivity is 
involved in the progression of microvascular dysfunction associated with 
hypercholesterolemia. However, it was not clear how impaired FSS related pseudopod 
retraction would manifest into microvascular dysfunction. Since we previously 
demonstrated that pathologic cholesterol elevations impair FSS mechanosensitivity 
through an effect on membrane fluidity, it remained possible that membrane cholesterol 
enrichment would impair FSS-induced Mac1 cleavage. Blocking Mac1 cleavage would 
disrupt the FSS-induced control of neutrophil adhesion, as we showed using our 
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detachment assay, potentially contributing to the dysregulated neutrophil adhesion 
observed during hypercholesterolemia [29,77,173]. 
In the present study, we identified a dose-dependent inhibitory effect of exogenous 
cholesterol elevations on FSS-induced cleavage of Mac1 integrins. The threshold 
concentration of cholesterol that completely blocked this FSS response (> 2 μg/mL) was 
consistent with the concentration our laboratory previously reported to impair FSS-induced 
pseudopod retraction (> 1 μg/mL) [27]. Notably, FSS-induced Mac1 cleavage is only 
partially blocked in cells treated with 1 μg/mL cholesterol. This suggests that, because FSS-
induced pseudopod retraction is completely blocked at 1 μg/mL cholesterol, the attenuated 
Mac1 cleavage keeps enough adhesion integrins intact which are capable of forming 
membrane-substrate interactions to prevent pseudopod retraction. 
After we established 2 μg/mL as the threshold concentration of cholesterol required 
to impair FSS-induced Mac1 cleavage, we adopted our previously reported strategy 
involving the membrane fluidizer, BnOH, to recover cholesterol-related blockade of FSS-
induced pseudopod retraction [27]. We also used a second compound known to fluidize 
cell membranes, EtOH. Notably, these membrane fluidizers recovered FSS-induced Mac1 
cleavage at concentrations of 1 – 2 mM for BnOH and 7 – 8 mM for EtOH. Importantly, 
the ability of 1 – 2 mM BnOH to recover FSS-induced Mac1 cleavage was in agreement 
with that observed previously (1 mM BnOH) to recover FSS-induced pseudopod retraction 
by neutrophils treated with 2 µg/mL cholesterol [27]. Despite the difference in fluidizer 
concentrations, the ability of BnOH and EtOH to reverse the cholesterol blockade of FSS-
induced Mac1 cleavage provided further evidence supporting the existence of an optimal 
membrane fluidity level permissive for intact neutrophil FSS sensitivity. 
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 While we had linked changes in neutrophil membrane fluidity to the impairment of 
FSS-induced Mac1 cleavage, the exact mechanistic relationship remains to be elucidated. 
One possibility is that enriching neutrophil membranes with cholesterol impairs ctsB 
release. Membrane stiffening has been reported to prevent the release of pro-inflammatory 
cytokines into the extracellular milieu [106]. Thus, it is plausible that FSS-induced ctsB 
release is blocked by cholesterol-related changes to membrane fluidity. Our experiments 
confirmed that FSS-induced ctsB release was blocked at threshold cholesterol 
concentrations corresponding to those determined in Mac1 cleavage experiments. 
Importantly, it was possible to reverse the effects of cholesterol impairment by using BnOH 
and EtOH to recover FSS-induced ctsB release at the same membrane fluidizer 
concentrations (1 – 2 mM BnOH and 7 – 8 mM EtOH) used to reverse the blockade of 
FSS-induced Mac1 cleavage by cholesterol. 
 
6.3.2 Cholesterol-related changes in membrane fluidity block fluid shear stress-mediated 
restriction of neutrophil adhesion 
 Our next set of experiments focused on the physiologic implications of this 
impaired mechanotransduction response. In particular, we wanted to determine if 
cholesterol-related impairment of FSS-induced ctsB release and Mac1 cleavage impairs 
the ability of FSS to restrict neutrophil adhesion. Using our flow-based detachment assay 
with platelets as a biological substrate, we demonstrated that neutrophils enriched with 
cholesterol became unresponsive to FSS exposure and remained adherent to platelet 
monolayers despite being exposed to flow. These observations are in line with the reported 
ability of cholesterol to enhance neutrophil tethering and firm arrest to activated 
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endothelium [126], suggesting that cholesterol may, in fact, block the FSS-induced 
regulation of cell adhesion. 
Notably, it was possible to reverse the cholesterol-related impairment of FSS-
induced neutrophil detachment from platelet layers using either BnOH or EtOH. More 
importantly, the concentrations of BnOH and EtOH that recovered FSS-induced 
detachment by cholesterol-treated neutrophils were the same as those required to recover 
FSS-induced Mac1 cleavage in similarly-treated cells. These observations, combined with 
previous results from our laboratory, provided evidence that cholesterol-related changes in 
membrane fluidity impair FSS-induced ctsB release and Mac1 cleavage, leading to 
dysregulated neutrophil adhesion under flow. Considering that elevated neutrophil 
adhesion and activity have been linked with hypercholesterolemia and other downstream 
cardiovascular pathologies [29,80,174,175], the results presented in this chapter implicated 
cholesterol-related impairment of FSS-induced Mac1 cleavage as a contributing factor. 
 
6.4 The Contributions of Hypercholesterolemia-Related Impairment of Fluid Shear 
Stress Mechanotransduction in the Development of Microvascular Dysfunction 
6.4.1 Pathologic cholesterol elevations associated with hypercholesterolemia impair fluid 
shear stress-induced Mac1 cleavage 
 In order to verify that impairment of the Mac1 cleavage response to FSS may occur 
in the in vivo setting of hypercholesterolemia, we performed studies on neutrophils from 
LDLR-/- mice. When LDLR-/- mice are fed a HFD, they gradually develop 
hypercholesterolemia as plasma levels of free and total cholesterol increase over the 
duration of dieting [176]. We verified this for our study since the LDLR-/- mice on a HFD 
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displayed gradual increases in blood cholesterol levels over the 6- and 8-week durations 
tested in the present study. Previous studies have shown that leukocytes from humans and 
animals with pathological blood cholesterol levels have significantly elevated 
concentrations of membrane cholesterol, with associated reductions in membrane fluidity 
[172,177]. Overall, this suggests that feeding LDLR-/- mice a HFD was sufficient to: i) 
induce a hypercholesterolemic state; ii) enrich the neutrophil membrane with cholesterol; 
and iii) reduce the membrane fluidity of neutrophils. 
 Neutrophils from LDLR-/- mice fed a ND and exposed to FSS were observed to 
have an intact Mac1 cleavage response to FSS, similar to that observed for human 
neutrophils. However, neutrophils from our HFD mice exposed to FSS exhibited an 
impaired Mac1 cleavage response. While 6 weeks of HFD was sufficient to attenuate FSS-
induced Mac1 cleavage, 8 weeks of HFD completely blocked shear-induced Mac1 
cleavage. Notably, we also observed that the degree to which FSS-induced Mac1 cleavage 
was blocked was positively correlated with the plasma cholesterol concentrations (free and 
total) of LDLR-/- mice. Therefore, it is likely that a gradual impairment of FSS-induced 
Mac1 cleavage follows gradual increases of plasma cholesterol levels. 
The current study is not the first to determine that impairment of FSS 
mechanotransduction is dependent on the length of time that mice were fed a HFD. 
Previous studies have reported similar relationships linking diet duration with an impaired 
FSS-induced pseudopod retraction response [27]. In that study, the mice fed a HFD for as 
little as 2 weeks exhibited a deficit in their responsiveness to FSS exposure. However, the 
fraction of neutrophils that retracted pseudopods gradually decreased as HFD progressed. 
After 8 weeks of HFD, neutrophils from hypercholesterolemic mice appeared to extend 
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pseudopods in response to shear exposure; i.e., a reverse shear response. These past 
observations, combined with the present study, indicate that FSS mechanotransduction is 
impaired to a greater degree as membrane cholesterol content increases. Notably, a 
significant finding of the present study was demonstrating that hypercholesterolemia also 
impairs FSS control of neutrophil adhesion, which has mechanistic implications in 
hypercholesterolemia-related pathogenesis.  
 
6.4.2 Cholesterol-related impairment of fluid shear stress-induced Mac1 cleavage is 
correlated with dysregulated tissue blood flow in hypercholesterolemic mice 
Since we demonstrated that cholesterol can impair FSS-induced Mac1 cleavage, 
we also wanted to determine whether pathologic cholesterol elevations associated with 
hypercholesterolemia and its detrimental impact on the FSS regulation of Mac1 surface 
expression contribute to dysregulated tissue blood flow in LDLR-/- mice. Therefore, we 
analyzed the ability of LDLR-/- mice to recover blood flow in hind limbs after 5 minutes of 
occlusion, which is similar to poRH in humans [129,131]. The recovery in blood flow was 
quantified as the peak flow, reported as APF, immediately after cuff removal. We also 
reported the duration of time after cuff removal (i.e., tissue reperfusion) to reach APF, 
reported as tAPF. 
Hypercholesterolemic mice fed a HFD for 6 and 8 weeks displayed what appeared 
to be an impaired poRH response, as APF was decreased and tAPF was increased in 
comparison to ND mice. Since poRH can be used as an estimation of microvascular 
function and tissue blood flow autoregulation, this suggested that tissue blood flow was 
disrupted in hypercholesterolemic mice. However, we did not observe a significant 
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different between ND and HFD mice for both APF and tAPF, unlike in previous studies 
from our lab [26]. This is likely due to the low statistical power in our analyses, as our 
results were based on data from 4 mice in each group, independent of diet type and diet 
duration. During earlier studies, the weight of the DCS probe was found to interfere with 
the rBF data acquired by DCS during poRH. By placing the probe under the mouse leg, 
rather than on top of the leg, we eliminated the source of error for future experiments. In 
the future, we would expect at least 7 – 8 mice in each experimental group would be needed 
to detect significant differences similar to that previously reported for APF and tAPF [26]. 
We also performed correlation analyses to determine how plasma cholesterol levels 
were linked with the poRH response in mice, independent of diet type and diet duration. 
Our correlation analyses found that APF in LDLR-/- mice was negatively correlated with 
plasma cholesterol levels and, most importantly, this correlation was significant. Thus, 
elevations in cholesterol appear to have an effect of reducing APF. An interpretation of this 
outcome may be that pathological cholesterol concentrations associated with 
hypercholesterolemia contribute to dysregulated tissue blood flow, which is in agreement 
with prior reports for mice and humans [26,80,128]. Additionally, tAPF was positively 
correlated with plasma cholesterol levels, indicating that elevations in cholesterol lengthen 
the amount of time necessary to achieve a complete poRH response. Since poRH can be 
used to estimate tissue blood flow autoregulation, we can interpret this data to say that 
blood cholesterol levels are prognostic of an impairment in tissue blood flow 
autoregulation.  This agrees with numerous reports demonstrating a link between blood 
cholesterol levels and the progression of microvascular dysfunction [178,179]. 
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We also found that APF was negatively correlated with the degree to which FSS-
induced Mac1 cleavage was blocked, independent of diet type and duration. These results 
point to cholesterol-related impairment of FSS-induced Mac1 cleavage as a potential factor 
that contributes to hypercholesterolemia-related reductions in APF. Specifically, FSS-
induced regulation of neutrophil adhesion may be compromised by blocking Mac1 
cleavage under FSS exposure, potentially resulting in dysregulated neutrophil adhesion 
characteristic of the hypercholesterolemic microcirculation [29,77,173]. Notably, 
dysregulated neutrophil adhesion has been demonstrated to contribute, in part, to the 
progression of microvascular dysfunction [4,50,128,180-182]. Therefore, it is conceivable 
that the disrupted tissue blood flow in our studies, which manifested as decreased APF, 
resulted from the cholesterol-related impairment of FSS regulatory mechanisms.  
Overall, the results from our mice study, combined with those from our human 
neutrophil detachment experiments, implicate the cholesterol-related dysregulation of 
neutrophil behavior in the progression of microvascular dysfunction associated with the 
onset and progression of hypercholesterolemia. This relationship between neutrophil 
adhesion, FSS-induced Mac1 cleavage, and dysregulated tissue blood flow may help 
design future studies to definitively link an impaired FSS response to the progression of 
microvascular dysfunction. 
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CHAPTER 7: CONCLUSIONS 
 In summary, the evidence provided in this study supports the importance of FSS 
mechanotransduction in the physiologic control of neutrophil activity. Specifically, this 
dissertation provided new evidence that cleavage of Mac1 by FSS-induced ctsB release 
serves to regulate neutrophil adhesion to unstimulated endothelium. By downregulating the 
expression of Mac1 adhesion integrins, FSS mechanotransduction likely ensures 
neutrophils remain quiescent and freely-floating in the circulation. We also provided 
evidence for the existence of an optimal membrane fluidity level permissive of an intact 
Mac1 cleavage response to flow. Perturbations that alter the membrane fluidity outside this 
optimal range are expected to impair the physiological regulation of neutrophil activity by 
FSS, thereby contributing to pathology. 
Additionally, we report that cholesterol-related changes in membrane fluidity may 
lead to impairment of the FSS-related control of neutrophil adhesion by Mac1 cleavage. 
This has implications during hypercholesterolemia where blood cholesterol elevations, by 
impairing FSS-induced ctsB release and Mac1 cleavage, may promote dysregulated 
neutrophil adhesion in the microvasculature and, in doing so, lead to microvascular 
dysfunction. Ultimately, these results suggest that dysregulated neutrophil adhesion, 
induced by cholesterol-related impairment of FSS mechanotransduction, may be one of the 
earliest upstream factors which disrupt tissue blood flow and contribute to microvascular 
dysfunction, a precursor to lethal vascular disease due to hypercholesterolemia. 
Future studies should focus on further elucidating mechanistic aspects of this 
potential link between dysregulated neutrophil adhesion and microvascular dysfunction. 
For example, intravital microscopy can be used to monitor neutrophil adhesion to the 
endothelium under flow conditions in hypercholesterolemic mice. By using a micropipette 
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to first induce blood stasis followed by its removal to reconstitute microvascular flow, it 
would be possible to determine whether adherent neutrophils in hypercholesterolemic mice 
respond to shear exposure. Additionally, studies in ctsB-deficient mice can be performed 
in parallel with those from LDLR-/- mice to determine if a loss of ctsB activity is also linked 
to dysregulated neutrophil adhesion and microvascular dysfunction in vivo. This would 
suggest that the dysregulated adhesion of cholesterol-enriched neutrophils in 
hypercholesterolemic mice may be due to a loss in ctsB activity, likely due to membrane 
fluidity-related impairment of ctsB release. Verification of ctsB release from cholesterol-
enriched neutrophils can then be determined using single-molecule tracking with 
fluorescently labeled ctsB. Finally, it is important to understand the early 
mechanosignaling events at the mechanosensor and secondary messenger levels to better 
understand the mechanobiology of neutrophils under FSS exposure. Overall, these studies 
may contribute toward the development of novel therapeutic treatments that target 
cholesterol-related pathobiology (e.g., impairment of FSS mechanotransduction in 
neutrophils) rather than just targeting blood cholesterol levels, a strategy that is still 
controversial in terms of its efficacy. 
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APPENDIX A 
A.1 Introduction 
Peripheral hemodynamic resistance is affected by activated neutrophils, either 
through capillary plugging or adhesion to the microvasculature [183,184]. However, 
neutrophils flowing through the blood in an inactivated state also influence apparent 
viscosity [72,142], which affects flow resistance. We performed in vitro experiments to 
test whether activated neutrophils could significantly enhance their impact on 
microvascular flow by altering blood rheology. In this regard, we sought in vitro 
affirmation that sustained neutrophil activation may impact peripheral resistance and 
downstream tissue perfusion, both of which may contribute to microvascular pathobiology. 
The following description of this study is derived with minor modifications from 
our previously published work: 
Akenhead ML, Horrall NM, Rowe D, Sethu P, Shin HY. In Vitro Evaluation of the Link 
Between Cell Activation State and Its Rheological Impact on the Microscale Flow of 
Neutrophil Suspensions. ASME. J Biomech Eng. 2015;137(9):091003-091003-10. 
 
A.2 Methods 
A.2.1 Microfluidics-based microvascular mimics 
To evaluate the impact of neutrophil pseudopod activity on flow resistance in 
microfluidics mimics of non-capillary (i.e., arteriolar/venular) microvessels, we utilized 
two different experimental configurations. One configuration utilized a 
polydimethylsiloxane (PDMS) chamber consisting of a single rectangular cross-section 
microchannel (w: 500 µm; h: 50 µm; l: 20 mm). We also simulated a microvascular 
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network by utilizing a PDMS chamber with twenty 20x50 µm rectangular channels 
arranged in parallel. 
Prior to experimentation, neutrophil suspensions (1x106 cells/ml) were stimulated 
with 0 or 10 nM fMLP for 5 min and subsequently fixed in 1% p-formaldehyde. The 
neutrophil suspensions were perfused through the microfluidic chamber for 3 minutes at 
flow rates of 1, 1.5, 2, and 5 mL/min in the absence or presence of autologous erythrocytes 
at 10% hematocrit. During perfusion, we measured the infusion pressure (relative to the 
atmosphere). For analyses, the baseline pressure reading (Pt=0) (obtained before the onset 
of flow) was subtracted from each instantaneous infusion pressure reading (Pt), and used 
as the instantaneous pressure gradient ∆P = Pt - Pt=0. To reduce the impact of noise, we 
averaged the pressure gradient values recorded over the last 2 min of constant flow (Q) at 
each flow rate. These averages were then used to quantify the flow resistance (slope of a 
∆P vs. Q curve). 
 
A.3 Results 
A.3.1 The rheological impact of neutrophil activation is enhanced by the presence of 
erythrocytes in microscale flows 
  To simulate flow without plugging through the largest microvessels within the 
microcirculation, we utilized a single-channel microchamber during experiments. Both 
activated and inactivated neutrophil suspensions were observed to have similar perfusion 
pressures during flow through this chamber (Fig. A.1, A). We also simulated microscale 
flow by utilizing a microvascular network chamber during experiments. Much like the 
single channel microchamber, both activated and inactivated neutrophil suspensions were 
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observed to have similar perfusion pressures during flow through the microvascular 
network chamber (Fig. A.1, B). Based on the pressure vs. flow curves generated for each 
chamber (Fig. A.1, C), activated and inactivated cell suspensions were determined to have 
a similar impact on flow resistance (Table A.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Figure A.1. In the absence of erythrocytes, neutrophil activation does not significantly 
impact the flow properties of microvascular mimics. 
(A-B) Plots of perfusion pressure versus time for a single 500x50 µm channel (A) or a network 
of twenty 20x50µm microchannels (B) were generated at various flow rates (0, 1, 1.5, 2, and 5 
mL/hr) for purified neutrophil suspensions maintained in an inactivated state (solid black line) 
or activated with 10 nM fMLP (solid red line). (C) To determine effects of neutrophil activation 
on microchannel flow resistance, pressure versus flow curves were generated from the raw data. 
Pressure values were averaged over the last 2 minutes recorded at each flow rate. From the 
generated curves, resistance values corresponding to single channel (inactivated, open triangles; 
activated, solid triangle) or microvascular network (inactivated, open circles; activated, solid 
circles) were found by computing the slope of each line. Points are mean ± SEM. n = 3. 
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  Resistance (cmH2O/(mL/hr) P-value 
  Inactivated Activated 
Single 
Channel 18.92 ± 6.26 18.65 ± 5.54 P > 0.05 
Multi- 
Network 27.89 ± 3.76 27.9 ± 3.28 P > 0.05 
 
  Similar experiments were repeated in the presence of 10% hematocrit to evaluate 
the contributions of erythrocytes. The perfusion pressure readings obtained from the flow 
of activated neutrophil populations for both the single-channel microchamber (Fig. A.2, A) 
and the micronetwork chamber (Fig. A.2, B) appeared to be elevated in comparison to that 
of inactivated neutrophil populations. In line with this, activated neutrophils in the presence 
of erythrocytes appeared to increase the slope of the pressure flow curves for both chambers 
(Fig. A.2, C). Quantitatively, while the baseline resistance to neutrophil perfusion of both 
chambers was increased by the addition of 10% hematocrit alone, fMLP stimulation, when 
combined with erythrocytes, significantly (P < 0.05) elevated the flow resistance of both 
chambers (Table A.2). Notably, the increase in flow resistance of the micronetwork 
chamber due to neutrophil activation in the presence of hematocrit was significantly (P < 
0.05) higher than that of the single-channel microchamber (Table A.3). 
 
 
 
 
 
Table A.1. Summary of flow resistance during neutrophil perfusion. 
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  Resistance (cmH2O/(mL/hr) P-value 
  Inactivated Activated 
Single 
Channel 21.91 ± 6.87 22.7 ± 7.41 P < 0.05 
Multi- 
Network 31.98 ± 2.21 34.91 ± 3.44 P < 0.05 
 
Figure A.2. Suspensions of activated neutrophils and erythrocytes significantly impact 
the flow properties of microvascular mimics. 
(A-B) Plots of perfusion pressure versus time for a single 500x50 µm channel (A) or a network 
of twenty 20x50µm microchannels (B) were generated at various flow rates (0, 1, 1.5, 2, and 5 
mL/hr) for purified neutrophil suspensions maintained in an inactivated state (solid black line) 
or activated with 10 nM fMLP (solid red line), and subsequently supplemented with 10% 
hematocrit. (C) To determine effects of neutrophil activation on microchannel flow resistance, 
pressure versus flow curves were generated from the raw data. Pressure values were averaged 
over the last 2 minutes recorded at each flow rate. From the generated curves, resistance values 
corresponding to single channel (inactivated, open triangles; activated, solid triangle) or 
microvascular network (inactivated, open circles; activated, solid circles) were found by 
computing the slope of each line. Points are mean ± SEM. n = 3. 
 
Table A.2. Summary of flow resistance during neutrophil and erythrocyte perfusion. 
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 Percent Difference 
 0% Hct  10% Hct 
Single 
Channel 1.4%  3.61%* 
Multi- 
Network 0.035%  9.16%*
# 
 
 
A.3.2 Summary of findings/interpretations 
The results of the present study provided evidence for the following significant findings. 
• Neutrophil activation in blood-like cell suspensions enhances the flow resistance of 
microscale channels of sizes representative of those found for non-capillary 
microvasculature. 
• Hematocrit is an important contributor to the effects of neutrophil activation on the 
flow resistance of microchannels. 
 
Table A.3. The contributions of erythrocytes in elevating flow resistance. 
*P < 0.05 compared to 0% difference (one-sample t-test) 
#P < 0.05 compared to percent difference in single channel (Student’s t test) 
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